User Image Cart Icon 0 Search Image

Metabolic Reprogramming

  1. Metabolic reprogramming: the emerging concept and associated therapeutic strategies
  2. HIF1α and Metabolic reprogramming in inflammation
  3. Lipid Metabolic reprogramming in cancer cells
  4. Metabolic reprogramming: a cancer hallmark even warburg did not anticipate
  5. Metabolic reprogramming of the tumor
  6. miRNAs link Metabolic reprogramming to oncogenesis
  7. Metabolic reprogramming of immune cells in cancer progression
  8. The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
  9. Metabolic reprogramming and Metabolic dependency in T cells
  10. Metabolic reprogramming in glioma
  11. Oxygen availability and Metabolic reprogramming in cancer
  12. Lipid Metabolic reprogramming in hepatocellular carcinoma
  13. Metabolic reprogramming during neuronal differentiation
  14. Metabolic reprogramming of stem cell epigenetics
  15. The transcription factor Myc controls Metabolic reprogramming upon T lymphocyte activation
  16. Anti-inflammatory effect of IL-10 mediated by Metabolic reprogramming of macrophages
  17. Metabolic reprogramming, caloric restriction and aging
  18. Linking Metabolic reprogramming to therapy resistance in cancer
  19. Oncogenic regulation of tumor Metabolic reprogramming
  20. Metabolic reprogramming and epithelial‐to‐mesenchymal transition in cancer
  21. Regulation of immune cell functions by Metabolic reprogramming
  22. Oxidative stress, tumor microenvironment, and Metabolic reprogramming: a diabolic liaison
  23. Metabolic reprogramming in macrophages and dendritic cells in innate immunity
  24. Metabolic reprogramming of the tumour microenvironment
  25. Cancer metabolism: key players in Metabolic reprogramming
  26. Contribution of Metabolic reprogramming to macrophage plasticity and function
  27. Reciprocal Metabolic reprogramming through lactate shuttle coordinately influences tumor-stroma interplay
  28. Metabolic reprogramming by class I and II histone deacetylases
  29. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis
  30. Dysregulated Metabolic enzymes and Metabolic reprogramming in cancer cells
  31. Control of nutrient stress-induced Metabolic reprogramming by PKCζ in tumorigenesis
  32. Metabolic reprogramming by viruses in the sunlit and dark ocean
  33. Energy Metabolic reprogramming in the hypertrophied and early stage failing heart: a multisystems approach
  34. Viral Metabolic reprogramming in marine ecosystems
  35. Metabolic reprogramming in brain tumors
  36. Clinical significance of T cell Metabolic reprogramming in cancer
  37. Metabolic reprogramming of cancer-associated fibroblasts by IDH3α downregulation
  38. Metabolic reprogramming of natural killer cells in obesity limits antitumor responses
  39. mTORC2 in the center of cancer Metabolic reprogramming
  40. Metabolic reprogramming of periwinkle plant culture
  41. Metabolic reprogramming in clear cell renal cell carcinoma
  42. Influence of the tumor microenvironment on cancer cells Metabolic reprogramming
  43. Cancer Metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies
  44. The autophagy conundrum in cancer: influence of tumorigenic Metabolic reprogramming
  45. Analysis of hypoxia-induced Metabolic reprogramming
  46. Molecular drivers of cellular Metabolic reprogramming in melanoma
  47. The role of YAP/TAZ activity in cancer Metabolic reprogramming
  48. Global Metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC
  49. Metabolic reprogramming: a hallmark of viral oncogenesis
  50. Metabolic reprogramming and tolerance during sepsis-induced AKI
  51. Metabolic reprogramming by the PI3K-Akt-mTOR pathway in cancer
  52. PDK1-dependent Metabolic reprogramming dictates metastatic potential in breast cancer
  53. Metabolic reprogramming during TGFβ1-induced epithelial-to-mesenchymal transition
  54. Nrf2 redirects glucose and glutamine into anabolic pathways in Metabolic reprogramming
  55. Metabolic reprogramming supports IFN-γ production by CD56bright NK cells
  56. Genetically-defined Metabolic reprogramming in cancer
  57. Cell-autonomous Metabolic reprogramming in hypoxia
  58. A role for the Krebs cycle intermediate citrate in Metabolic reprogramming in innate immunity and inflammation
  59. Targeting Metabolic reprogramming in KRAS-driven cancers
  60. Targeting Metabolic reprogramming by influenza infection for therapeutic intervention
  61. ADHFE1 is a breast cancer oncogene and induces Metabolic reprogramming
  62. Metabolic reprogramming in amyotrophic lateral sclerosis
  63. Metabolic reprogramming in chloroplasts under heat stress in plants
  64. Metabolic reprogramming for cancer cells and their microenvironment: Beyond the Warburg Effect
  65. Similarities in the Metabolic reprogramming of immune system and endothelium
  66. Akt-dependent Metabolic reprogramming regulates tumor cell histone acetylation
  67. Novel drugs that target the Metabolic reprogramming in renal cell cancer
  68. Tissue-specific Metabolic reprogramming drives nutrient flux in diabetic complications
  69. Metabolic reprogramming of alloantigen-activated T cells after hematopoietic cell transplantation
  70. Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma
  71. mTORC1-dependent Metabolic reprogramming is a prerequisite for NK cell effector function
  72. Autophagy in stem cells: repair, remodelling and Metabolic reprogramming
  73. Control of amino-acid transport by antigen receptors coordinates the Metabolic reprogramming essential for T cell differentiation
  74. Metabolic reprogramming is required for myofibroblast contractility and differentiation
  75. Grade-dependent Metabolic reprogramming in kidney cancer revealed by combined proteomics and metabolomics analysis
  76. Metabolic reprogramming and dysregulated metabolism: cause, consequence and/or enabler of environmental carcinogenesis?
  77. Metabolic reprogramming in dietary restriction
  78. Nrf2-mediated Metabolic reprogramming in cancer
  79. The role of Metabolic reprogramming in T cell fate and function
  80. Metabolic reprogramming in thyroid carcinoma
  81. Initial B cell activation induces Metabolic reprogramming and mitochondrial remodeling
  82. Molecular mechanisms of Metabolic reprogramming in proliferating cells: implications for T‐cell‐mediated immunity
  83. Mutant Kras copy number defines Metabolic reprogramming and therapeutic susceptibilities
  84. Metabolic reprogramming in glioblastoma: the influence of cancer metabolism on epigenetics and unanswered questions
  85. The emerging “hallmarks” of Metabolic reprogramming and immune evasion: distinct or linked?
  86. IAPP-driven Metabolic reprogramming induces regression of p53-deficient tumours in vivo
  87. Metabolic reprogramming during the Trypanosoma brucei life cycle
  88. The Warburg effect version 2.0: Metabolic reprogramming of cancer stem cells
  89. Metabolic reprogramming of cancer associated fibroblasts: the slavery of stromal fibroblasts
  90. Metabolic reprogramming supports the invasive phenotype in malignant melanoma
  91. The effect of immunosuppressive molecules on T-cell Metabolic reprogramming
  92. Metabolic reprogramming during neuronal differentiation from aerobic glycolysis to neuronal oxidative phosphorylation
  93. Translational and HIF-1α-dependent Metabolic reprogramming underpin Metabolic plasticity and responses to kinase inhibitors and biguanides
  94. Metabolic reprogramming of host cells upon bacterial infection: Why shift to a Warburg‐like metabolism?
  95. Metabolomics and Metabolic reprogramming in kidney cancer
  96. Metabolic reprogramming of mitochondrial respiration in metastatic cancer
  97. Targeting the Metabolic reprogramming that controls epithelial-to-mesenchymal transition in aggressive tumors
  98. Metabolic reprogramming as a novel regulator of skeletal muscle development and regeneration
  99. Metabolic reprogramming of macrophages: glucose transporter 1 (GLUT1)-mediated glucose metabolism drives a proinflammatory phenotype
  100. Biomarkers of coordinate Metabolic reprogramming in colorectal tumors in mice and humans
  101. Mitochondrial Metabolic reprogramming induced by calorie restriction
  102. TLR-mediated Metabolic reprogramming in the tumor microenvironment: potential novel strategies for cancer immunotherapy
  103. Complement regulates nutrient influx and Metabolic reprogramming during Th1 cell responses
  104. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells
  105. Metabolic reprogramming in modulating T cell reactive oxygen species generation and antioxidant capacity
  106. Role of SLC7A5 in Metabolic reprogramming of human monocyte/macrophage immune responses
  107. Metabolic reprogramming in the tumour microenvironment: a hallmark shared by cancer cells and T lymphocytes
  108. Reciprocal regulation of Metabolic reprogramming and epigenetic modifications in cancer
  109. BNIP3L/NIX-dependent mitophagy regulates cell differentiation via Metabolic reprogramming
  110. Metabolic reprogramming in plant innate immunity: the contributions of phenylpropanoid and oxylipin pathways
  111. Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
  112. Metabolic reprogramming of non-Hodgkin’s B-cell lymphomas and potential therapeutic strategies
  113. Metabolic reprogramming towards aerobic glycolysis correlates with greater proliferative ability and resistance to Metabolic inhibition in CD8 versus CD4 T …
  114. Mitofusins deficiency elicits mitochondrial Metabolic reprogramming to pluripotency
  115. VEGF‐B‐induced vascular growth leads to Metabolic reprogramming and ischemia resistance in the heart
  116. Human dendritic cell subsets undergo distinct Metabolic reprogramming for immune response
  117. xCT (SLC7A11)-mediated Metabolic reprogramming promotes non-small cell lung cancer progression
  118. Loss of the tumor suppressor LKB1 promotes Metabolic reprogramming of cancer cells via HIF-1α
  119. T cell Metabolic reprogramming and plasticity
  120. PD-1 alters T-cell Metabolic reprogramming by inhibiting glycolysis and promoting lipolysis and fatty acid oxidation
  121. LPA induces Metabolic reprogramming in ovarian cancer via a pseudohypoxic response
  122. HIF-1-mediated Metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of cancers in lungs
  123. Metabolic reprogramming in type 2 diabetes and the development of breast cancer
  124. Metabolic reprogramming ensures cancer cell survival despite oncogenic signaling blockade
  125. Metabolic reprogramming mediated by the mTORC2-IRF4 signaling axis is essential for macrophage alternative activation
  126. Metabolic reprogramming identifies the most aggressive lesions at early phases of hepatic carcinogenesis
  127. Metabolic reprogramming in mutant IDH1 glioma cells
  128. Metabolic reprogramming of carcinoma-associated fibroblasts and its impact on Metabolic heterogeneity of tumors
  129. Alterations in the vaginal microbiome by maternal stress are associated with Metabolic reprogramming of the offspring gut and brain
  130. Role of mesenchymal stem cells in osteosarcoma and Metabolic reprogramming of tumor cells
  131. T cell exit from quiescence and differentiation into Th2 cells depend on Raptor-mTORC1-mediated Metabolic reprogramming
  132. Glycosphingolipid Metabolic reprogramming drives neural differentiation
  133. Metabolic reprogramming & inflammation: Fuelling the host response to pathogens
  134. Metabolic reprogramming of pancreatic cancer mediated by CDK4/6 inhibition elicits unique vulnerabilities
  135. Inflammation-modulated Metabolic reprogramming is required for DUOX-dependent gut immunity in Drosophila
  136. Quantitative H2S-mediated protein sulfhydration reveals Metabolic reprogramming during the integrated stress response
  137. Myokine mediated muscle-kidney crosstalk suppresses Metabolic reprogramming and fibrosis in damaged kidneys
  138. Deregulated Myc requires MondoA/Mlx for Metabolic reprogramming and tumorigenesis
  139. Metabolic reprogramming in triple-negative breast cancer through Myc suppression of TXNIP
  140. On Metabolic reprogramming and tumor biology: A comprehensive survey of metabolism in breast cancer
  141. Fatty acid Metabolic reprogramming via mTOR-mediated inductions of PPARγ directs early activation of T cells
  142. Metabolic reprogramming and longevity of tissue-resident memory T cells
  143. Aldolase B-mediated fructose metabolism drives Metabolic reprogramming of colon cancer liver metastasis
  144. “Metabolic reprogramming” in ovarian cancer cells resistant to cisplatin
  145. Store-operated Ca2+ entry controls clonal expansion of T cells through Metabolic reprogramming
  146. mTORC1-dependent Metabolic reprogramming underlies escape from glycolysis addiction in cancer cells
  147. Hallmarks of pulmonary hypertension: mesenchymal and inflammatory cell Metabolic reprogramming
  148. Metabolic reprogramming-based characterization of circulating tumor cells in prostate cancer
  149. Molecular pathways: targeting MYC-induced Metabolic reprogramming and oncogenic stress in cancer
  150. Metabolic reprogramming in the pathogenesis of chronic lung diseases, including BPD, COPD, and pulmonary fibrosis
  151. Metabolic reprogramming enables hepatocarcinoma cells to efficiently adapt and survive to a nutrient-restricted microenvironment
  152. Placental Metabolic reprogramming: do changes in the mix of energy-generating substrates modulate fetal growth?
  153. Branched chain amino acid Metabolic reprogramming in heart failure
  154. GFPT2-expressing cancer-associated fibroblasts mediate Metabolic reprogramming in human lung adenocarcinoma
  155. ATM couples replication stress and Metabolic reprogramming during cellular senescence
  156. Nrf2 negatively regulates STING indicating a link between antiviral sensing and Metabolic reprogramming
  157. IL-23 and IL-1β drive human Th17 cell differentiation and Metabolic reprogramming in absence of CD28 costimulation
  158. Metformin-induced Metabolic reprogramming of chemoresistant ALDHbright breast cancer cells
  159. BCAT1 controls Metabolic reprogramming in activated human macrophages and is associated with inflammatory diseases
  160. Targeting Metabolic reprogramming as a potential therapeutic strategy in melanoma
  161. Coactivator SRC-2–dependent Metabolic reprogramming mediates prostate cancer survival and metastasis
  162. Metabolic reprogramming of acute lymphoblastic leukemia cells in response to glucocorticoid treatment
  163. Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia
  164. Oncogenic KRAS and BRAF drive Metabolic reprogramming in colorectal cancer
  165. Modelling central Metabolic fluxes by constraint‐based optimization reveals Metabolic reprogramming of developing Solanum lycopersicum (tomato) fruit
  166. Metabolic reprogramming of the tumor microenvironment by p62 and its partners
  167. Metabolic reprogramming of stromal fibroblasts through p62-mTORC1 signaling promotes inflammation and tumorigenesis
  168. Starvation signals in yeast are integrated to coordinate Metabolic reprogramming and stress response to ensure longevity
  169. Oxidative modifications of glyceraldehyde 3-phosphate dehydrogenase regulate Metabolic reprogramming of stored red blood cells
  170. Jasmonate signaling involves the abscisic acid receptor PYL4 to regulate Metabolic reprogramming in Arabidopsis and tobacco
  171. MicroRNAs and oncogenic transcriptional regulatory networks controlling Metabolic reprogramming in cancers
  172. Oxidative dimerization of PHD2 is responsible for its inactivation and contributes to Metabolic reprogramming via HIF-1α activation
  173. A key role for transketolase-like 1 in tumor Metabolic reprogramming
  174. Oxidative stress and Metabolic reprogramming in Cr (VI) carcinogenesis
  175. HIF-1α is required for disturbed flow-induced Metabolic reprogramming in human and porcine vascular endothelium
  176. NRF2 facilitates breast cancer cell growth via HIF1ɑ-mediated Metabolic reprogramming
  177. Metabolic reprogramming and inflammation act in concert to control vascular remodeling in hypoxic pulmonary hypertension
  178. p62/Sqstm1 promotes malignancy of HCV-positive hepatocellular carcinoma through Nrf2-dependent Metabolic reprogramming
  179. Loss of GLUT4 induces Metabolic reprogramming and impairs viability of breast cancer cells
  180. Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent Metabolic reprogramming of stromal cells
  181. Chronic inflammation confers to the Metabolic reprogramming associated with tumorigenesis of colorectal cancer
  182. Interferon gamma induces reversible Metabolic reprogramming of M1 macrophages to sustain cell viability and pro-inflammatory activity
  183. Ionizing radiation impairs T cell activation by affecting Metabolic reprogramming
  184. Metabolomics of oncogene-specific Metabolic reprogramming during breast cancer
  185. NOX4 functions as a mitochondrial energetic sensor coupling cancer Metabolic reprogramming to drug resistance
  186. Metabolic reprogramming of human cells in response to oxidative stress: implications in the pathophysiology and therapy of mitochondrial diseases
  187. Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment
  188. Metabolic reprogramming of metastatic breast cancer and melanoma by let-7a microRNA
  189. Targeting lipid Metabolic reprogramming as anticancer therapeutics
  190. ATF4 regulates CD4+ T cell immune responses through Metabolic reprogramming
  191. Metabolic reprogramming and dependencies associated with epithelial cancer stem cells independent of the epithelial‐mesenchymal transition program
  192. Nitric oxide triggers a transient Metabolic reprogramming in Arabidopsis
  193. Quantitative Proteomics of Intracellular Campylobacter jejuni Reveals Metabolic reprogramming
  194. Switching of pyruvate kinase isoform L to M2 promotes Metabolic reprogramming in hepatocarcinogenesis
  195. Redox regulation of the epigenetic landscape in cancer: a role for Metabolic reprogramming in remodeling the epigenome
  196. Metabolic reprogramming during multidrug resistance in Leukemias
  197. Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer
  198. TPO-induced Metabolic reprogramming drives liver metastasis of colorectal cancer CD110+ tumor-initiating cells
  199. Elicitor-induced transcription factors for Metabolic reprogramming of secondary metabolism in Medicago truncatula
  200. Metabolic reprogramming of cancer-associated fibroblasts by TGF-β drives tumor growth: connecting TGF-β signaling with “Warburg-like” cancer metabolism and L …
  201. SIRT3 controls cancer Metabolic reprogramming by regulating ROS and HIF
  202. … stem cells harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining human embryonic stem cell–like Metabolic reprogramming
  203. Metabolic reprogramming in polycystic kidney disease
  204. Comprehensive proteomics analysis reveals Metabolic reprogramming of tumor-associated macrophages stimulated by the tumor microenvironment
  205. Jagged1/Notch2 controls kidney fibrosis via Tfam-mediated Metabolic reprogramming
  206. Metabolic reprogramming of human CD8+ memory T cells through loss of SIRT1
  207. White-to-brite conversion in human adipocytes promotes Metabolic reprogramming towards fatty acid anabolic and catabolic pathways
  208. Metabolic reprogramming of the heart through stearoyl-CoA desaturase
  209. Disruption of cytochrome c oxidase function induces the Warburg effect and Metabolic reprogramming
  210. Human mesenchymal stromal cell-secreted lactate induces M2-macrophage differentiation by Metabolic reprogramming
  211. Transcriptional and Translational Downregulation of Thioredoxin Interacting Protein Is Required for Metabolic reprogramming during G1
  212. Mitochondrial pyruvate carrier function determines cell stemness and Metabolic reprogramming in cancer cells
  213. Lactate inhibits the pro-inflammatory response and Metabolic reprogramming in murine macrophages in a GPR81-independent manner
  214. Improper excess light energy dissipation in Arabidopsis results in a Metabolic reprogramming
  215. Protein kinase C-β dictates B cell fate by regulating mitochondrial remodeling, Metabolic reprogramming, and heme biosynthesis
  216. Transforming growth factor-β induced Warburg-like Metabolic reprogramming may underpin the development of peritoneal endometriosis
  217. DJ-1 links muscle ROS production with Metabolic reprogramming and systemic energy homeostasis in mice
  218. Metabolic reprogramming of myeloid-derived suppressor cells (MDSC) in cancer
  219. Interplay between sirtuins, MYC and hypoxia-inducible factor in cancer-associated Metabolic reprogramming
  220. Metabolic reprogramming of the premalignant colonic mucosa is an early event in carcinogenesis
  221. Metabolic reprogramming of Clostridioides difficile during the stationary phase with the induction of toxin production
  222. Quantitative proteomics by SWATH-MS reveals sophisticated Metabolic reprogramming in hepatocellular carcinoma tissues
  223. The thioredoxin-1 system is essential for fueling DNA synthesis during T-cell Metabolic reprogramming and proliferation
  224. Metabolic reprogramming for producing energy and reducing power in fumarate hydratase null cells from hereditary leiomyomatosis renal cell carcinoma
  225. Drp1 controls effective T cell immune-surveillance by regulating T cell migration, proliferation, and cMyc-dependent Metabolic reprogramming
  226. Transcriptional and Metabolic reprogramming induce an inflammatory phenotype in non-medullary thyroid carcinoma-induced macrophages
  227. KPNA2 promotes Metabolic reprogramming in glioblastomas by regulation of c-myc
  228. Metabolic reprogramming by dual AKT/ERK inhibition through imipridones elicits unique vulnerabilities in glioblastoma
  229. Metabolic reprogramming during Purine Stress in the Protozoan Pathogen Leishmania donovani
  230. Autophagy-dependent Metabolic reprogramming sensitizes TSC2-deficient cells to the antimetabolite 6-aminonicotinamide
  231. Transcription factor RD 26 is a key regulator of Metabolic reprogramming during dark‐induced senescence
  232. Metabolic reprogramming by folate restriction leads to a less aggressive cancer phenotype
  233. EWS/FLI is a master regulator of Metabolic reprogramming in Ewing sarcoma
  234. Crosstalk between two bZIP signaling pathways orchestrates salt-induced Metabolic reprogramming in Arabidopsis roots
  235. Metabolic reprogramming and oncogenesis: one hallmark, many organelles
  236. Environmental Toxin–Linked Nonalcoholic Steatohepatitis and Hepatic Metabolic reprogramming in Obese Mice
  237. Lactobacillus johnsonii supplementation attenuates respiratory viral infection via Metabolic reprogramming and immune cell modulation
  238. Aberrant IDH3α expression promotes malignant tumor growth by inducing HIF-1-mediated Metabolic reprogramming and angiogenesis
  239. The mitochondrial Metabolic reprogramming agent trimetazidine as an ‘exercise mimetic’in cachectic C26‐bearing mice
  240. Metabolic reprogramming: a new relevant pathway in adult adrenocortical tumors
  241. Metabolic reprogramming and two-compartment tumor metabolism: opposing role (s) of HIF1α and HIF2α in tumor-associated fibroblasts and human breast cancer …
  242. Arginine deiminase resistance in melanoma cells is associated with Metabolic reprogramming, glucose dependence, and glutamine addiction
  243. Lsd1 ablation triggers Metabolic reprogramming of brown adipose tissue
  244. Metabolomic analysis of bone morphogenetic protein receptor type 2 mutations in human pulmonary endothelium reveals widespread Metabolic reprogramming
  245. Including the mitochondrial metabolism of L-lactate in cancer Metabolic reprogramming
  246. Dose-dependent Metabolic reprogramming and differential gene expression in TCDD-elicited hepatic fibrosis
  247. Acute loss of iron–sulfur clusters results in Metabolic reprogramming and generation of lipid droplets in mammalian cells
  248. Metabolic reprogramming in keloid fibroblasts: aerobic glycolysis and a novel therapeutic strategy
  249. Metabolic reprogramming through fatty acid transport protein 1 (FATP1) regulates macrophage inflammatory potential and adipose inflammation
  250. mTORC1 promotes Metabolic reprogramming by the suppression of GSK3-dependent Foxk1 phosphorylation
  251. Metabolic reprogramming and the recovery of physiological functionality in 3D cultures in micro-bioreactors
  252. Isotopically nonstationary 13C flux analysis of Myc-induced Metabolic reprogramming in B-cells
  253. Noncoding RNAs in regulation of cancer Metabolic reprogramming
  254. Metabolic reprogramming by PCK1 promotes TCA cataplerosis, oxidative stress and apoptosis in liver cancer cells and suppresses hepatocellular carcinoma
  255. Model-driven discovery of long-chain fatty acid Metabolic reprogramming in heterogeneous prostate cancer cells
  256. PKM2-dependent Metabolic reprogramming in CD4+ T cells is crucial for hyperhomocysteinemia-accelerated atherosclerosis
  257. Caught in the cROSsfire: GSH controls T cell Metabolic reprogramming
  258. Dissection of Metabolic reprogramming in polycystic kidney disease reveals coordinated rewiring of bioenergetic pathways
  259. Nrf2 is a central regulator of Metabolic reprogramming of myeloid-derived suppressor cells in steady state and sepsis
  260. Hydrogen peroxide stress provokes a Metabolic reprogramming in Pseudomonas fluorescens: enhanced production of pyruvate
  261. Metabolic reprogramming of bone marrow stromal cells by leukemic extracellular vesicles in acute lymphoblastic leukemia
  262. Homocysteine activates B cells via regulating PKM2-dependent Metabolic reprogramming
  263. Tracking down the origin of cancer: Metabolic reprogramming as a driver of stemness and tumorigenesis
  264. The mitochondrial H+-ATP synthase and the lipogenic switch: New core components of Metabolic reprogramming in induced pluripotent stem (iPS) cells
  265. Metabolic reprogramming by HIF-1 promotes the survival of bone marrow–derived angiogenic cells in ischemic tissue
  266. Control of amino acid transport coordinates Metabolic reprogramming in T-cell malignancy
  267. Metabolic reprogramming in the heart and lung in a murine model of pulmonary arterial hypertension
  268. Metabolic reprogramming and Validation of Hyperpolarized 13C Lactate as a Prostate Cancer Biomarker Using a Human Prostate Tissue Slice Culture Bioreactor
  269. Metabolic reprogramming in leaf lettuce grown under different light quality and intensity conditions using narrow-band LEDs
  270. Metabolic reprogramming commits differentiation of human CD27+ IgD+ B cells to plasmablasts or CD27− IgD− cells
  271. Metabolic reprogramming and AMPKα1 pathway activation by caulerpin in colorectal cancer cells
  272. Photoreceptor Metabolic reprogramming provides survival advantage in acute stress while causing chronic degeneration
  273. AMPK Activation and Metabolic reprogramming by Tamoxifen through Estrogen Receptor–Independent Mechanisms Suggests New Uses for This Therapeutic …
  274. GLUT3 upregulation promotes Metabolic reprogramming associated with antiangiogenic therapy resistance
  275. Resveratrol impedes the stemness, epithelial-mesenchymal transition, and Metabolic reprogramming of cancer stem cells in nasopharyngeal carcinoma …
  276. Lipid Metabolic reprogramming in hepatic ischemia–reperfusion injury
  277. mTORC2 and Metabolic reprogramming in GBM: at the interface of genetics and environment
  278. The role of Metabolic reprogramming in γ‐herpesvirus‐associated oncogenesis
  279. Metabolic reprogramming by hexosamine biosynthetic and Golgi N-glycan branching pathways
  280. Hypoxic repression of pyruvate dehydrogenase activity is necessary for Metabolic reprogramming and growth of model tumours
  281. Autophagic reliance promotes Metabolic reprogramming in oncogenic KRAS-driven tumorigenesis
  282. Bergapten induces Metabolic reprogramming in breast cancer cells
  283. Glucose-6-phosphate dehydrogenase and transketolase modulate breast cancer cell Metabolic reprogramming and correlate with poor patient outcome
  284. TRAF3 deficiency promotes Metabolic reprogramming in B cells
  285. Silibinin-mediated Metabolic reprogramming attenuates pancreatic cancer-induced cachexia and tumor growth
  286. Loss of function of miR-342-3p results in MCT1 over-expression and contributes to oncogenic Metabolic reprogramming in triple negative breast cancer
  287. DNMT1 mediates Metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma
  288. Integrated metabolomics and lipidomics analyses reveal Metabolic reprogramming in human glioma with IDH1 mutation
  289. Reconstructed Metabolic network models predict flux-level Metabolic reprogramming in glioblastoma
  290. Butyrate suppresses the proliferation of colorectal cancer cells via targeting pyruvate kinase M2 and Metabolic reprogramming
  291. Emerging function of mTORC2 as a core regulator in glioblastoma: Metabolic reprogramming and drug resistance
  292. Adipocytes fuel gastric cancer omental metastasis via PITPNC1-mediated fatty acid Metabolic reprogramming
  293. Metabolic reprogramming by the pyruvate dehydrogenase kinase–lactic acid axis: Linking metabolism and diverse neuropathophysiologies
  294. Structural and functional insight of sphingosine 1-phosphate-mediated pathogenic Metabolic reprogramming in sickle cell disease
  295. The TORC1-regulated CPA complex rewires an RNA processing network to drive autophagy and Metabolic reprogramming
  296. Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent Metabolic reprogramming
  297. Metabolic reprogramming by 3-iodothyronamine (T1AM): a new perspective to reverse obesity through co-regulation of sirtuin 4 and 6 expression
  298. Quantitative 1 H NMR metabolomics reveals extensive Metabolic reprogramming of primary and secondary metabolism in elicitor-treated opium poppy cell …
  299. Metabolic reprogramming and apoptosis sensitivity: Defining the contours of a T cell response
  300. Metabolic reprogramming underlies metastatic potential in an obesity-responsive murine model of metastatic triple negative breast cancer
  301. SOCS1 is a negative regulator of Metabolic reprogramming during sepsis
  302. Critical roles of mTORC1 signaling and Metabolic reprogramming for M-CSF–mediated myelopoiesis
  303. Epidemiological-molecular evidence of Metabolic reprogramming on proliferation, autophagy and cell signaling in pancreas cancer
  304. Paracoccidioides brasiliensis presents Metabolic reprogramming and secretes a serine proteinase during murine infection
  305. Metabolic reprogramming of glioblastoma cells by L-asparaginase sensitizes for apoptosis in vitro and in vivo
  306. Metabolic reprogramming of Macrophages Exposed to Silk, Poly(lactic‐co‐glycolic acid), and Silica Nanoparticles
  307. Metabolic reprogramming during hepatitis B disease progression offers novel diagnostic and therapeutic opportunities
  308. Metabolic reprogramming regulates the proliferative and inflammatory phenotype of adventitial fibroblasts in pulmonary hypertension through the transcriptional …
  309. miR-155 drives Metabolic reprogramming of ER+ breast cancer cells following long-term estrogen deprivation and predicts clinical response to aromatase inhibitors
  310. A novel and safe small molecule enhances hair follicle regeneration by facilitating Metabolic reprogramming
  311. Phosphorus and iron deficiencies induce a Metabolic reprogramming and affect the exudation traits of the woody plant Fragaria×ananassa
  312. The impact of Metabolic reprogramming on dendritic cell function
  313. New insight into the role of Metabolic reprogramming in melanoma cells harboring BRAF mutations
  314. Pyruvate imbalance mediates Metabolic reprogramming and mimics lifespan extension by dietary restriction in Caenorhabditis elegans
  315. The Metabolic reprogramming Evoked by Nitrosative Stress Triggers the Anaerobic Utilization of Citrate in Pseudomonas fluorescens
  316. Fusarium oxysporum mediates systems Metabolic reprogramming of chickpea roots as revealed by a combination of proteomics and metabolomics
  317. Inflexibility of AMPK-mediated Metabolic reprogramming in mitochondrial disease
  318. Does Metabolic reprogramming underpin age-associated changes in T cell phenotype and function?
  319. Relationship between Metabolic reprogramming and mitochondrial activity in cancer cells. Understanding the anticancer effect of metformin and its clinical …
  320. Metabolic reprogramming under microaerobic and anaerobic conditions in bacteria
  321. The airway epithelium undergoes Metabolic reprogramming in individuals at high risk for lung cancer
  322. Testicular Metabolic reprogramming in neonatal streptozotocin-induced type 2 diabetic rats impairs glycolytic flux and promotes glycogen synthesis
  323. Metabolic reprogramming in cancer cells, consequences on pH and tumour progression: Integrated therapeutic perspectives with dietary lipids as adjuvant to …
  324. The environmental carcinogen benzo [a] pyrene induces a Warburg-like Metabolic reprogramming dependent on NHE1 and associated with cell survival
  325. CD73 on T cells orchestrates cardiac wound healing after myocardial infarction by purinergic Metabolic reprogramming
  326. Deep quantitative proteomics reveals extensive Metabolic reprogramming and cancer-like changes of ectopic endometriotic stromal cells
  327. LSD1 mediates Metabolic reprogramming by glucocorticoids during myogenic differentiation
  328. Increased butyrate priming in the gut stalls microbiome associated-gastrointestinal inflammation and hepatic Metabolic reprogramming in a mouse model of Gulf War …
  329. Hypothalamic responses to fasting indicate Metabolic reprogramming away from glycolysis toward lipid oxidation
  330. … RNAs enforce their will on mitochondrial activity: regulation of mitochondrial respiration, reactive oxygen species production, apoptosis, and Metabolic reprogramming …
  331. Antagonistic role of natural compounds in mTOR-mediated Metabolic reprogramming
  332. Cinnamaldehyde induces fat cell-autonomous thermogenesis and Metabolic reprogramming
  333. Photoperiod extension enhances sexual megaspore formation and triggers Metabolic reprogramming in facultative apomictic Ranunculus auricomus
  334. Metabolism and development–integration of micro computed tomography data and metabolite profiling reveals Metabolic reprogramming from floral initiation to silique …
  335. Metabolic reprogramming via PPARα signaling in cardiac hypertrophy and failure: from metabolomics to epigenetics
  336. Eukaryotic translation initiation factor 5A2 promotes Metabolic reprogramming in hepatocellular carcinoma cells
  337. Cooperative STAT/NF-κB signaling regulates lymphoma Metabolic reprogramming and aberrant GOT2 expression
  338. Fecal microbiota transplantation in experimental ulcerative colitis reveals associated gut microbial and host Metabolic reprogramming
  339. Pyruvate Kinase Isoform Switching and Hepatic Metabolic reprogramming by the Environmental Contaminant 2,3,7,8-Tetrachlorodibenzo-p-Dioxin
  340. Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia
  341. Impact of chemotherapy on Metabolic reprogramming: Characterization of the Metabolic profile of breast cancer MDA-MB-231 cells using 1H HR-MAS NMR …
  342. Metabolic reprogramming of murine cardiomyocytes during autophagy requires the extracellular nutrient sensor decorin
  343. Acute myeloid leukemia cells require 6-phosphogluconate dehydrogenase for cell growth and NADPH-dependent Metabolic reprogramming
  344. Acclimation-induced Metabolic reprogramming contributes to rapid desiccation tolerance acquisition in Boea hygrometrica
  345. Nrf2 promotes oesophageal cancer cell proliferation via Metabolic reprogramming and detoxification of reactive oxygen species
  346. EZH2 promotes Metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling
  347. Metabolic reprogramming by HIF‐1 activation enhances survivability of human adipose‐derived stem cells in ischaemic microenvironments
  348. The platelet isoform of phosphofructokinase contributes to Metabolic reprogramming and maintains cell proliferation in clear cell renal cell carcinoma
  349. Inhibitor of differentiation 1 transcription factor promotes Metabolic reprogramming in hepatocellular carcinoma cells
  350. Dynamin 2-dependent endocytosis sustains T-cell receptor signaling and drives Metabolic reprogramming in T lymphocytes
  351. Integrated phosphoproteomic and metabolomic profiling reveals NPM-ALK–mediated phosphorylation of PKM2 and Metabolic reprogramming in anaplastic large cell …
  352. Asparagine deprivation mediated by Salmonella asparaginase causes suppression of activation‐induced T cell Metabolic reprogramming
  353. Soluble factors from stellate cells induce pancreatic cancer cell proliferation via Nrf2-activated Metabolic reprogramming and ROS detoxification
  354. The role of HIF-1 in oncostatin M-dependent Metabolic reprogramming of hepatic cells
  355. Cell Stress, Metabolic reprogramming, and Cancer
  356. Clk1 deficiency promotes neuroinflammation and subsequent dopaminergic cell death through regulation of microglial Metabolic reprogramming
  357. Metabolic reprogramming of host cells by virulent Francisella tularensis for optimal replication and modulation of inflammation
  358. Cigarette smoke induces mitochondrial Metabolic reprogramming in lung cells
  359. Metformin and caffeic acid regulate Metabolic reprogramming in human cervical carcinoma SiHa/HTB-35 cells and augment anticancer activity of Cisplatin via cell …
  360. Farnesoid X receptor activation promotes cell proliferation via PDK4-controlled Metabolic reprogramming
  361. … of Vdac1 activates hypoxia-inducible factor through reactive oxygen species generation and induces tumor growth by promoting Metabolic reprogramming …
  362. … 6-phosphogluconate dehydrogenase reverses doxorubicin resistance in anaplastic thyroid cancer via inhibiting NADPH-dependent Metabolic reprogramming
  363. … cascade‐triggered overexpression of CEMIP promotes migration and invasion in anoikis‐resistant prostate cancer cells by enhancing Metabolic reprogramming
  364. Metabolic reprogramming of the urea cycle pathway in experimental pulmonary arterial hypertension rats induced by monocrotaline
  365. UCP2 induces Metabolic reprogramming to inhibit proliferation of cancer cells
  366. HMGA1 drives Metabolic reprogramming of intestinal epithelium during hyperproliferation, polyposis, and colorectal carcinogenesis
  367. CD147: a small molecule transporter ancillary protein at the crossroad of multiple hallmarks of cancer and Metabolic reprogramming
  368. Intraperitoneal delivery of a novel liposome-encapsulated paclitaxel redirects Metabolic reprogramming and effectively inhibits cancer stem cells in Taxol® …
  369. PPARα antagonist AA452 triggers Metabolic reprogramming and increases sensitivity to radiation therapy in human glioblastoma primary cells
  370. Interscapular brown adipose tissue Metabolic reprogramming during cold acclimation: Interplay of HIF-1α and AMPKα
  371. 1H NMR Spectroscopy Profiling of Metabolic reprogramming of Chinese Hamster Ovary Cells upon a Temperature Shift during Culture
  372. Dynamic Metabolic reprogramming of steroidal glycol-alkaloid and phenylpropanoid biosynthesis may impart early blight resistance in wild tomato (Solanum arcanum …
  373. Mitochondrial mechanisms of Metabolic reprogramming in proliferating cells
  374. Toll‐like receptor 3 stimulation triggers Metabolic reprogramming in pharyngeal cancer cell line through Myc, MAPK, and HIF
  375. Nrf2-mediated Metabolic reprogramming of tolerogenic dendritic cells is protective against aplastic anemia
  376. … 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer Metabolic reprogramming
  377. Metastatic cancer cells compensate for low energy supplies in hostile microenvironments with bioenergetic adaptation and Metabolic reprogramming
  378. Resveratrol stimulates the Metabolic reprogramming of human CD4+ T cells to enhance effector function
  379. δ-Catenin, a Wnt/β-catenin modulator, reveals inducible mutagenesis promoting cancer cell survival adaptation and Metabolic reprogramming
  380. Indoleamine 2, 3-dioxygenase regulates anti-tumor immunity in lung cancer by Metabolic reprogramming of immune cells in the tumor microenvironment
  381. Compartment-specific activation of PPARγ governs breast cancer tumor growth, via Metabolic reprogramming and symbiosis
  382. Quantitative 1H-NMR-Metabolomics Reveals Extensive Metabolic reprogramming and the Effect of the Aquaglyceroporin FPS1 in Ethanol-Stressed Yeast …
  383. Differential gene expression pattern in hypothalamus of chickens during fasting-induced Metabolic reprogramming: Functions of glucose and lipid metabolism …
  384. Recent advances in the role of AMP-activated protein kinase in Metabolic reprogramming of metastatic cancer cells: targeting cellular bioenergetics and biosynthetic …
  385. Antioxidant modifications induced by the new metformin derivative HL156A regulate Metabolic reprogramming in SAMP1/kl (-/-) mice
  386. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma Metabolic reprogramming: Trichostatin A as a case study
  387. Quantitative proteomics suggests Metabolic reprogramming during ETHE1 deficiency
  388. FGF9‐induced ovarian cancer cell invasion involves VEGF‐A/VEGFR2 augmentation by virtue of ETS1 upregulation and Metabolic reprogramming
  389. Mitochondrial resetting and Metabolic reprogramming in induced pluripotent stem cells and mitochondrial disease modeling
  390. Hepatic glucose-6-phosphatase-α deficiency leads to Metabolic reprogramming in glycogen storage disease type Ia
  391. Metabolic reprogramming and redox signaling in pulmonary hypertension
  392. Pluripotency transcription factors and Metabolic reprogramming of mitochondria in tumor-initiating stem-like cells
  393. Downregulation of TRAP1 sensitizes glioblastoma cells to temozolomide chemotherapy through regulating Metabolic reprogramming
  394. Cell surface GRP78 promotes tumor cell histone acetylation through Metabolic reprogramming: a mechanism which modulates the Warburg effect
  395. Metabolic reprogramming and cell fate regulation in alcoholic liver disease
  396. Estradiol-17β upregulates pyruvate kinase M2 expression to coactivate estrogen receptor-α and to integrate Metabolic reprogramming with the mitogenic response in …
  397. Investigate the Metabolic reprogramming of Saccharomyces cerevisiae for Enhanced Resistance to Mixed Fermentation Inhibitors via 13C Metabolic Flux …
  398. Untargeted metabolomics reveals distinct Metabolic reprogramming in endothelial cells co-cultured with CSC and non-CSC prostate cancer cell …
  399. miR-125b regulates differentiation and Metabolic reprogramming of T cell acute lymphoblastic leukemia by directly targeting A20
  400. Metabolic reprogramming in cancer: the art of balance
  401. Stimulation of the toll-like receptor 3 promotes Metabolic reprogramming in head and neck carcinoma cells
  402. ADHFE1 is a MYC-linked oncogene that induces Metabolic reprogramming and cellular de-differentiation in breast cancer
  403. Defects in the mitochondrial-tRNA modification enzymes MTO1 and GTPBP3 promote different Metabolic reprogramming through a HIF-PPARγ-UCP2-AMPK …
  404. Evaluation of mitochondrial function and Metabolic reprogramming during tumor progression in a cell model of skin carcinogenesis
  405. Candida albicans induces Metabolic reprogramming in human NK cells and responds to perforin with a zinc depletion response
  406. Naloxone, but not valsartan, preserves responses to hypoglycemia after antecedent hypoglycemia: role of Metabolic reprogramming in counterregulatory failure
  407. Metabolic reprogramming of Vibrio cholerae impaired in respiratory NADH oxidation is accompanied by increased copper sensitivity
  408. Mammalian SWI/SNF enzymes and the epigenetics of tumor cell Metabolic reprogramming
  409. Arsenic hyperaccumulation induces Metabolic reprogramming in Pityrogramma calomelanos to reduce oxidative stress
  410. Reply to Yoshida: Liver cancer stem cells: Identification and lipid Metabolic reprogramming
  411. Metabolic reprogramming, autophagy, and reactive oxygen species are necessary for primordial germ cell reprogramming into pluripotency
  412. Regulation of SIRT3 signal related Metabolic reprogramming in gastric cancer by Helicobacter pylori oncoprotein CagA
  413. Metabolic reprogramming is associated with flavopiridol resistance in prostate cancer DU145 cells
  414. Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study
  415. Statin-induced Metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters
  416. PDHA1 gene knockout in prostate cancer cells results in Metabolic reprogramming towards greater glutamine dependence
  417. mTORC2 contributes to the Metabolic reprogramming in EGFR tyrosine-kinase inhibitor resistant cells in non-small cell lung cancer
  418. Metabolic reprogramming of the immune response in the tumor microenvironment
  419. 2‐methoxyestradiol impacts on amino acids‐mediated Metabolic reprogramming in osteosarcoma cells by its interaction with NMDA receptor
  420. Clinically relevant HIF-1α-dependent Metabolic reprogramming in oropharyngeal squamous cell carcinomas includes coordinated activation of CAIX and the …
  421. The miRNAome dynamics during developmental and Metabolic reprogramming of tomato root infected with potato cyst nematode
  422. Body mass index is associated with region-dependent Metabolic reprogramming of adipose tissue
  423. A systems analysis with “simplified source-sink model” reveals Metabolic reprogramming in a pair of source-to-sink organs during early fruit development in …
  424. The cell cycle regulator 14-3-3σ opposes and reverses cancer Metabolic reprogramming
  425. New insights into Behçet’s syndrome Metabolic reprogramming: citrate pathway dysregulation
  426. Post-transcriptional regulation of gene expression in response to iron deficiency: co-ordinated Metabolic reprogramming by yeast mRNA-binding proteins
  427. Metabolic reprogramming in disseminated cells
  428. MTOR-Driven Metabolic reprogramming Regulates Legionella pneumophila Intracellular Niche Homeostasis
  429. Uncoupling protein 2 regulates Metabolic reprogramming and fate of antigen-stimulated CD8+ T cells
  430. Detachment from the primary site and suspension in ascites as the initial step in Metabolic reprogramming and metastasis to the omentum in ovarian cancer
  431. Canceromics studies unravel tumor’s glutamine addiction after Metabolic reprogramming
  432. Metabolic reprogramming by Dichloroacetic acid potentiates photodynamic therapy of human breast adenocarcinoma MCF-7 cells
  433. Nrf2 and AhR in Metabolic reprogramming after contaminant exposure
  434. Systematic investigation of Metabolic reprogramming in different cancers based on tissue-specific Metabolic models
  435. Integrated omics-analysis reveals Wnt-mediated NAD+ Metabolic reprogramming in cancer stem-like cells
  436. Feeling energetic? New strategies to prevent Metabolic reprogramming in melanoma
  437. Combined metabonomic and quantitative RT-PCR analyses revealed Metabolic reprogramming associated with Fusarium graminearum resistance in …
  438. Metabolic reprogramming in colon cancer reversed by DHTS through regulating PTEN/AKT/HIF1α mediated signal pathway
  439. GLUT1, MCT1/4 and CD147 overexpression supports the Metabolic reprogramming in papillary renal cell carcinoma
  440. The phosphatidylinositol 3, 5-bisphosphate (PI (3, 5) P2)-dependent Tup1 conversion (PIPTC) regulates Metabolic reprogramming from glycolysis to gluconeogenesis
  441. Human iPSCs harbor homoplasmic and heteroplasmic mitochondrial DNA mutations while maintaining hESC-like Metabolic reprogramming
  442. Small, Thin Graphene Oxide Is Anti-inflammatory Activating Nuclear Factor Erythroid 2-Related Factor 2 via Metabolic reprogramming
  443. Distinct physiological and Metabolic reprogramming by highbush blueberry (Vaccinium corymbosum) cultivars revealed during long‐term UV‐B radiation
  444. Erratum to: Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia
  445. AMBRA1 is involved in T cell receptor-mediated Metabolic reprogramming through an ATG7-independent pathway
  446. Halofuginone reduces the inflammatory responses of DSS-induced colitis through Metabolic reprogramming
  447. Mitochondria/Metabolic reprogramming in the formation of neurons from peripheral cells: cause or consequence and the implications to their utility
  448. PTEN elevation, autophagy and Metabolic reprogramming may be induced in human chondrocytes during steroids or nutrient depletion and osteoarthritis
  449. Metabolic reprogramming as a continuous changing behavior of tumor cells
  450. Eigenvalues of Jacobian matrices report on steps of Metabolic reprogramming in a complex plant-environment interaction
  451. … salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into Metabolic reprogramming of cancer cell …
  452. Metabolic reprogramming in cancer–a coordinated effort
  453. TFmeta: A machine learning approach to uncover transcription factors governing Metabolic reprogramming
  454. MicroRNA regulating Metabolic reprogramming in tumor cells: New tumor markers
  455. Metabolic reprogramming of pyruvate dehydrogenase is essential for the proliferation of glioma cells expressing mutant IDH1
  456. Does a similar Metabolic reprogramming occur in fe-deficient plant cells and animal tumor cells?
  457. A multi-omics analysis reveals Metabolic reprogramming in THP-1 cells upon treatment with the contact allergen DNCB
  458. PD-1 induces Metabolic reprogramming of activated T cells from glycolysis to lipid oxidation
  459. Loss of photosynthesis signals a Metabolic reprogramming to sustain sugar homeostasis during senescence of green leaves: Role of cell wall hydrolases
  460. c-Myc and AP4: a relay team for Metabolic reprogramming of CD8+ T cells
  461. Targeting Metabolic reprogramming as an anti-cancer strategy: aiming at monocarboxylate transporters
  462. Metabolic reprogramming and Hyaluronan Production in Cancer Stem Cells
  463. Metabolic reprogramming via targeting CD38 NADase augments adoptive T cell therapy
  464. Rab27B-Mediated Metabolic reprogramming Induces Secretome Acidification and Chemoresistance in Breast Cancer Cells
  465. Metabolic reprogramming in resting and activated immune cells
  466. Is age-related failure of Metabolic reprogramming a principal mediator in idiopathic Parkinson’s disease? Implications for treatment and inverse cancer risk
  467. NANOG-dependent Metabolic reprogramming and symmetric division in tumor-initiating stem-like cells
  468. reprogramming of basic Metabolic pathways in microbial sepsis: therapeutic targets at last?
  469. Chlamydia Anti-apoptosis–A By-product of Metabolic reprogramming?
  470. NRF2 orchestrates the Metabolic shift during induced pluripotent stem cell reprogramming
  471. Metabolic reprogramming induced by inhibition of SLC2A1 suppresses tumor progression in lung adenocarcinoma
  472. The role of protein conformational switches in pharmacology: its implications in Metabolic reprogramming and protein evolution
  473. FLCN: A new regulator of AMPK-dependent Warburg Metabolic reprogramming
  474. Metabolic reprogramming of T cells in RA
  475. Translating Metabolic reprogramming into new targets for kidney cancer
  476. Targeting cancer with tumor-specific therapeutic strategies–Metabolic reprogramming beyond the Warburg effect
  477. ERRs mediate a Metabolic switch required for somatic cell reprogramming to pluripotency
  478. P080 C-reactive protein: not only a marker, but also a cause of inflammation through Metabolic reprogramming of human macrophages
  479. p110α Hot Spot Mutations E545K and H1047R Exert Metabolic reprogramming Independently of p110α Kinase Activity
  480. CDC5L drives FAH expression to promote Metabolic reprogramming in melanoma
  481. The role of the GABA shunt in prostate cancer Metabolic reprogramming and aggressive phenotype
  482. Metabolic reprogramming after left ventricular assist device: remodeling without recovery of cardiac energetics
  483. The role of 6-phosphofructo-2-kinase (PFK-2)/fructose 2, 6-bisphosphatase (FBPase-2) in Metabolic reprogramming of cancer cells.
  484. Regulation of SIRT3 signal related Metabolic reprogramming in gastric cancer
  485. Wheat resistance to blast using a non-host selective toxin and host Metabolic reprogramming through a successful infection by Pyricularia oryzae
  486. Corrigendum: Metabolic reprogramming During Multidrug Resistance in Leukemias
  487. Highly time-resolved Metabolic reprogramming toward differential levels of phosphate in Chlamydomonas reinhardtii
  488. Elucidating the Metabolic plasticity of cancer: mitochondrial reprogramming and hybrid Metabolic states
  489. Role of oncogenes and tumor suppressors in Metabolic reprogramming and cancer therapeutics: A review
  490. Mitochondrial VDAC1 silencing leads to Metabolic rewiring and the reprogramming of tumour cells into advanced differentiated states
  491. Translational and HIF-1a-Dependent Metabolic reprogramming Underpin Metabolic Plasticity and Responses to Kinase Inhibitors and Biguanides
  492. reprogramming microbial Metabolic pathways
  493. Transcriptional reprogramming of Metabolic pathways in critically ill patients
  494. Lactate dehydrogenase acetylation adds another piece to the puzzle of Metabolic reprogramming in pancreatic cancer
  495. Metabolic reprogramming of triple-negative breast cancer: The role of miRNAs
  496. Molecular basis of glucose Metabolic reprogramming in cancer cells
  497. Metabolic regulation in pluripotent stem cells during reprogramming and self-renewal
  498. Metabolic reprogramming of human lung cancer cells and ex vivo tissues revealed by UHR-FTMS analysis of small amino and carboxyl metabolites
  499. Adaptive reprogramming of de novo pyrimidine synthesis is a Metabolic vulnerability in triple-negative breast cancer
  500. Metabolic reprogramming in KRAS mutant cancer cells may cause sensitivity to the histone deacetylase (HDAC) inhibitor romidepsin
  501. Using genetics, epigenetics and small molecules to reverse Metabolic reprogramming in adventitia fibroblasts for pulmonary hypertension therapy
  502. Metabolic reprogramming by KSHV in cellular transformation
  503. Metabolic reprogramming of myeloid-derived suppressive cells
  504. The role of macrophages in repair of injured myocardium and perspectives of Metabolic reprogramming of immune cells for myocardial post-infarction recovery
  505. Metabolic reprogramming of Acute Myeloid Leukemia Blasts By Bone Marrow Stroma Cells
  506. Adenosine signaling-mediated Metabolic reprogramming regulates erythropoiesis
  507. Metabolic reprogramming evoked by nitrosative stress enhances the effect of radiation in brain metastases.
  508. Nrf2 promotes esophageal cancer cell proliferation via Metabolic reprogramming and ROS detoxification
  509. X-ray irradiation induces mitophagy and cancer Metabolic reprogramming
  510. Mitochondrial Complex I inhibitor IACS-010759 reverses the NOTCH1-driven Metabolic reprogramming in T-ALL via blockade of oxidative phosphorylation …
  511. Data in support of Metabolic reprogramming in transformed mouse cortical astrocytes: A proteomic study
  512. LSC-2017-A critical role for mTOR regulated Metabolic reprogramming during TGF-β induced fibroblast collagen synthesis
  513. α-ketoglutarate orchestrates macrophage activation through Metabolic and epigenetic reprogramming
  514. An in vivo study into the Metabolic reprogramming of hepatocellular carcinoma
  515. Metabolic reprogramming of the cell: investigating systemic signatures and growth in cancer
  516. Metabolic reprogramming of Myeloid Cells in Response to Factors of “Emergency” Myelopoiesis by Myeloid-Specific PD-1 Ablation, Regulates Myeloid Lineage Fate …
  517. Inhibition of Metabolic reprogramming by zerumbone alters the tumorigenic potential of hepatocellular cancer
  518. Integrated energetics and flux analysis reveals differential Metabolic reprogramming in highly and less invasive cancer cells.
  519. Nutrient stress via folic acid modulation causes systemic and cancer-specific Metabolic reprogramming and differential effects on primary and metastatic mammary …
  520. … Stretch Combines With Adventitial Fibroblast-Derived Signals To Promote Macrophage Activation Through Metabolic reprogramming In Vascular Remodeling
  521. Receptor for advanced glycation end products (RAGE) regulates Metabolic reprogramming induced over-proliferation in pulmonary hypertension
  522. Conserved virulence-linked Metabolic reprogramming in Clostridioides difficile identified through
  523. Metabolic reprogramming Overcomes T Cell Inhibition By AML Cells
  524. Effect of Metabolic reprogramming on the Biological Activity of Acute Myeloid Leukemia Cells
  525. Metabolic switching and cell fate decisions: implications for pluripotency, reprogramming and development
  526. Tyrosine nitration induces a Metabolic reprogramming in neurofibromatosis type 2-associated Schwannoma cells
  527. TORquing Metabolic reprogramming in cancer cells
  528. PO-245 Fructose supports tumour growth and aggressiveness through a Metabolic reprogramming in prostate cancer
  529. CBMT-32. IMAGING A HALLMARK OF CANCER: TERT EXPRESSION LEADS TO MRS-DETECTABLE Metabolic reprogramming
  530. Metabolic reprogramming in cancer cells
  531. reprogramming of proline and glutamine metabolism contributes to the proliferative and Metabolic responses regulated by oncogenic transcription factor c-MYC
  532. Metabolic reprogramming by 3-Iodothyronamine
  533. Computational Analysis of Metabolic reprogramming in Tumors
  534. Ibrutinib-Resistant Mantle Cell Lymphoma Undergoes Metabolic reprogramming Towards Oxphos
  535. Exploring Cancer Cell Plasticity: Epithelial-Mesenchymal Transition and Metabolic reprogramming
  536. Metabolic reprogramming and Epigenetic Regulation in Renal Cell Carcinoma
  537. Metabolic reprogramming in ovarian cancer
  538. The role of Metabolic reprogramming in-herpesvirus-associated oncogenesis
  539. Characterization of intracellular Metabolic states in the origin of the Metabolic reprogramming of cancer cells
  540. HSP90 Facilitates Oncogene-Induced Metabolic reprogramming in B-Cell Lymphomas
  541. Electron transfer dictates Metabolic reprogramming in proliferating cells under hypoxia
  542. Metabolic reprogramming in Cancer and Metabolic Theory of CSC
  543. Metabolic and transcriptional reprogramming in developing soybean (Glycine max) embryos
  544. S-glutathionylation of pyruvate kinase M2 is associated with Metabolic reprogramming and cytokine production in the development of allergic obese airway disease
  545. Transcriptional control of Metabolic reprogramming by the Max-Mlx Network
  546. SAT0012 C-reactive protein: not only a marker, but also a cause of inflammation through Metabolic reprogramming of human macrophages
  547. Age-associated Metabolic reprogramming, oxidative stress response, and cancer progression
  548. Metabolic reprogramming cures liver disease
  549. Understanding Tumour Metabolic reprogramming with Metabolomics
  550. Treatment targeting the Metabolic reprogramming of cancers
  551. TGF-β1 signaling remodels TH17 cell chromatin architecture for Metabolic reprogramming
  552. Studying tumor Metabolic reprogramming through integration of metabolomics and transcriptomics
  553. Exploring Cancer Metabolic reprogramming through Molecular Imaging
  554. Role of PD-L1 immunoregulatory protein in breast cancer cells Metabolic reprogramming
  555. Abstract IA06: Molecular mechanisms of lung cancer development: Between Metabolic reprogramming and genomic instability in the field of cancerization
  556. Metabolic reprogramming in gastric cancer
  557. Reciprocal Metabolic reprogramming through Lactate Shuttle
  558. Adenosine A2B Receptor Controls Erythroid Lineage Commitment in Stress Erythropoiesis By Promoting Metabolic reprogramming
  559. Metabolic reprogramming by hydrogen sulfide
  560. Metabolic reprogramming by the Hexosamine Pathway and N-acetylglucosaminyltransferase
  561. EXTH-64. IMIPRIDONES CAUSE Metabolic reprogramming AND ELICIT UNIQUE VULNERABILITIES IN PRECLINICAL MODEL SYSTEMS OF …
  562. Targeting fructose-induced Metabolic reprogramming in liver metastasis
  563. NAD-Mediated Metabolic reprogramming Epigenetically Regulates Gene Expression to Promote Preadipocyte Differentiation
  564. TUMOR MICROENVIRONMENT INDUCES Metabolic reprogramming IN CANCER CELLS
  565. Suppression of SIRT2 and altered acetylation status of human pluripotent stem cells: possible link to Metabolic switch during reprogramming
  566. Transcription factor bZIP11 mediates Metabolic reprogramming
  567. Systems biology approach in understanding Metabolic reprogramming in breast cancer.
  568. Metabolic reprogramming of Dendritic Cells Is Controlled By the Mir-142
  569. Activation of Lxrβ Causes Metabolic reprogramming and Sensitizes Solid Tumors to Bcl-xL Inhibition Mediated Apoptosis
  570. Metabolic reprogramming of Stem Cell Epigenetics
  571. Phosphatase of Regenerative Liver-2 mediates cellular Metabolic reprogramming in breast cancer
  572. Elucidation of the role of Metabolic reprogramming in osteoclast differentiation
  573. The effect of immunosuppressive molecules on T-cell Metabolic reprogramming
  574. Cell fate and Metabolic reprogramming of tumor-initiating stem-like cells
  575. Lipid Metabolic reprogramming drives resistance to PD1 blockage
  576. Metabolic reprogramming with a Long Noncoding RNA
  577. HEME OXYGENASE-1 AND Metabolic reprogramming IN RESPONSE TO ISCHEMIA
  578. INNOVATIVE MEDICINE FOR Metabolic reprogramming OF INTRACTABLE CANCER STEM CELLS
  579. reprogramming a maize plant: transcriptional and Metabolic changes induced by the fungal biotroph Ustilago maydis
  580. METB-01 Metabolic reprogramming during resistance to anti-angiogenic therapy
  581. SIRT5 in cancer Metabolic reprogramming
  582. Cell intrinsic regulation of B cell activation: Metabolic reprogramming and mitochondrial remodelling
  583. CYTOPROTECTION AND Metabolic reprogramming GOVERNED BY KEAP1-NRF2 SYSTEM
  584. Abstract LB-198: Molecular drivers of Metabolic reprogramming during EMT
  585. Metabolic reprogramming in non-small cell lung cancer: a precision oncology approach
  586. Metabolic reprogramming may underpin the aetiology of endometriosis
  587. Analyzation of Metabolic reprogramming in Drug-Resistant MCF-7 Cells
  588. Tumor Cell Metabolic reprogramming and Drug Targeting
  589. Understanding the role of Metabolic reprogramming in breast cancer progression and metastasis
  590. Metabolic reprogramming upon CD8 T cell activation
  591. The role of Metabolic reprogramming in breast cancer progression and metastasis
  592. Metabolic reprogramming of Pancreatic Ductal Adenocarcinoma Cells in Response to Chronic Low pH Stress
  593. Vitamin E deficiency causes a Metabolic reprogramming dysregulating cellular energy homeostasis
  594. Targeting Lipid Metabolic reprogramming as Anticancer Therapeutics
  595. Metabolic reprogramming of myeloid cells during tumor progression
  596. OP0027 Abnormal B Cell Activation through Cellular Metabolic reprogramming and Its Relevance To The Pathogenesis of SLE
  597. Decoding Metabolic reprogramming by the AMPK pathway in cancer and Metabolic disease
  598. Human melanoma exosomes induce Metabolic reprogramming in human adult dermal fibroblasts
  599. Sirtuins in Cancer–Emerging Role as Modulators of Metabolic reprogramming
  600. Validation of NCM460 cell model as control in antitumor strategies targeting colon adenocarcinoma Metabolic reprogramming: Trichostatin A as a case study
  601. Metabolic reprogramming of oestrogen receptor positive breast cancer in endocrine therapy resistance
  602. Role of oncogene and tumor suppressor gene in tumor Metabolic reprogramming
  603. Metabolic reprogramming of the de novo fatty acid synthesis pathway in cancer devel-opment and progression
  604. Epithelial-Mesenchymal Transition and Metabolic reprogramming in Human Breast Cancer Cells
  605. Cigarette smoke induces Metabolic reprogramming in lung cells
  606. Abstract IA07: Metabolic reprogramming by MYC: Lessons learned from adenovirus
  607. CREB orchestrates Metabolic reprogramming in PDGFRA-addicted lung squamous cell cancer
  608. The Role of Acetylation in the Metabolic reprogramming of Cancer Cells
  609. PI3K-directed Metabolic reprogramming in thyroid cancer
  610. L-Asparaginase Causes Metabolic reprogramming in ALL Cells
  611. HSP90 Facilitates Oncogene-Induced Metabolic reprogramming in B-Cell Lymphomas
  612. Metabolic reprogramming by an epigenetic mechanism in endocrine therapy resistance of breast cancer
  613. Metabolic reprogramming of Macrophages Exposed to Pseudomonas aeruginosa Biofilm
  614. Metabolic reprogramming as therapeutic strategy to ameliorate skeletal muscle tissue engineering procedures
  615. Induction of differentiation and Metabolic reprogramming in human hepatoma cells by adult human serum
  616. Fueling immunity: The role of Myc in Metabolic reprogramming of activated T cells
  617. LSD1 mediates Metabolic reprogramming by glucocorticoids during myogenic differentiation
  618. Aldehyde Metabolic reprogramming in oesophageal adenocarcinoma
  619. Arsenic-induced Metabolic reprogramming: A Role for Autophagy, NRF2, and OGlcNAcylation
  620. Radiosensitization of Glioblastoma Stem Cells through Targeting Metabolic reprogramming
  621. Mitochondrial bioenergetic function and Metabolic plasticity in stem cell differentiation and cellular reprogramming
  622. Metabolic reprogramming of radiation fibrosis using adipose derived stromal cells
  623. Propofol induces Metabolic reprogramming and cell death in a mitochondrial electron transport chain-dependent manner
  624. SF3B1 mutations induce proteome remodeling, Metabolic reprogramming, and a novel kind of tumor surface antigen in human cells
  625. PPARαAntagonist AA452 Triggers Metabolic reprogramming and Increases Sensitivity to Radiation Therapy in Human Glioblastoma Primary Cells
  626. Metabolic reprogramming In Pulmonary Hypertension As Gleaned Through Mass Spectrometry-Based Metabolomics
  627. Metabolic reprogramming discriminates aggressive vs. slowly growing preneoplastic lesions at early stages of HCC development
  628. Abstract A02: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via Metabolic reprogramming
  629. Branched-Chain Amino Acid Metabolic reprogramming in Heart Failure
  630. Targeting Metabolic reprogramming associated to cancer cells: search of novel targets and combined therapies in cancer treatment
  631. reprogramming Metabolic pathways in vivo with CRISPR/Cas9 genome editing to treat hereditary tyrosinaemia
  632. Metabolic reprogramming of lignin biosynthesis in crops
  633. Glucose-dependent Metabolic reprogramming in HDAC5-depleted cancer cells
  634. Mitochondrial Metabolic reprogramming of Melanoma Cells Exposed to BRAFV600E Inhibitor
  635. PUB014 Collagen XVII Activates Oct4 and Alters Metabolic reprogramming through Upregulation of AKT/GSK-3β/β-catenin Pathway in Lung Cancer
  636. Reciprocal Metabolic reprogramming through Lactate Shuttle Coordinately Influences Tumor-Stroma Interplay
  637. Implicating Glucagon-like peptide-1 in the hormone-dependent Metabolic reprogramming observed in advanced prostate cancer
  638. Where do root exudates come from? Metabolic reprogramming under nutrient deficiency: Fe nutrition as a case study
  639. Adrenergic signaling impairs activation of CD8+ T cells by blocking Metabolic reprogramming
  640. Abstract SY01-02: Autophagy and Metabolic reprogramming in the tumor stroma
  641. Metabolic reprogramming in EMT-targeting regulatory nodes in mesenchymal cells
  642. Metabolic reprogramming in Mutant KRAS Colorectal Cancer Cells
  643. Abstract NG08: Transcriptional mechanisms for autophagy regulation and Metabolic reprogramming in pancreatic cancer
  644. Abstract B44: The epigenetic modifier CHAF1A opposes neuroblastoma differentiation via Metabolic reprogramming
  645. Epigenetic and Metabolic reprogramming as a target for prostate tumor radiosensitization
  646. mTORC1-dependent Metabolic reprogramming orchestrates T cell activation and fate decisions (IRM10P. 750)
  647. Evidence that the AMPK activator, Metformin, induced protection of the retina and RPE through Metabolic reprogramming
  648. A role for Noxa in human primary T cell activation and Metabolic reprogramming (LYM4P. 756)
  649. Curcumin Inhibit the proliferation of Ec109 cells via Metabolic reprogramming
  650. Abstract A99: Posttranscriptional gene regulation by HuR can explain Metabolic reprogramming in acutely stressed pancreatic cancer cells.
  651. Adipose tissue FABP deficiency promotes Metabolic reprogramming and positively impacts healthspan
  652. Propofol induces Metabolic reprogramming and cell death in a mitochondrial electron transport chain-dependent manner
  653. Isotopic tracing technique in quantitative analysis of Metabolic reprogramming in tumor cells
  654. Role of SIRT6 in Metabolic reprogramming During Colorectal Carcinoma
  655. Abstract SY22-02: Tumor suppression by p62 through the Metabolic reprogramming of the stroma
  656. Stromal epigenetic alterations drive Metabolic and neuroendocrine prostate cancer reprogramming
  657. New insights in the regulation of mitochondrial functions and Metabolic reprogramming by ERBB receptors in cancer
  658. Hepatic Metabolic reprogramming by Caloric Restriction in Rhesus Monkeys
  659. Metabolic reprogramming caused by mutations of the Fbw7 ubiquitin ligase in colorectal cancer
  660. Protein Kinase C-bDictates B Cell Fate by Regulating Mitochondrial Remodeling, Metabolic reprogramming, and Heme Biosynthesis
  661. Exportin-1 enables pro-tumorigenic Metabolic reprogramming of lung fibroblasts through relocalization of p53 and p62/SQSTM1
  662. Paracoccidioides brasiliensis presents Metabolic reprogramming and secretes a serine proteinase during murine infection Laurine Lacerda Pigosso1, Lilian …
  663. An insight into sono-activated nanoliposomes-mediated Metabolic reprogramming in liver of tumor-bearing mice
  664. Abstract B28: Multiplexed mass spectrometry analysis of KRAS-associated Metabolic reprogramming in colorectal tumors and cell lines
  665. Metabolic reprogramming in mutant IDH1 glioma cells
  666. Targeting Metabolic reprogramming In Macrophages Activated By Adventitial Fibroblasts In Pulmonary Hypertension As A New Potential Therapy Approach
  667. Metformin-dependent Metabolic reprogramming contributes to efficient anti-tumor immunity.
  668. Nox4 Negatively Regulates Metabolic reprogramming In Lung Fibroblasts
  669. The study of RAS-induced Metabolic reprogramming and the role of the pentose phosphate pathway in tumor metabolism
  670. The Metabolic reprogramming Evoked by Nitrosative Stress Triggers the Anaerobic
  671. TRIM24 orchestrates Metabolic reprogramming and EMT in Breast Cancer
  672. 30 Metabolic reprogramming in cd4+ cd28-cxcr3intt-bethi cells and its relevance to pathogenesis in patients with sle
  673. Apoptotic Cell Engulfment Triggers Anti-Inflammatory Metabolic reprogramming of Macrophages
  674. Role of macrophages Metabolic reprogramming and mitochondrial fission against Streptococcus pneumoniae
  675. Photoreceptor Metabolic reprogramming provides survival advantage in acute stress while causing chronic degeneration
  676. Modulation of Metabolic reprogramming in Macrophage Impacts the Pathogenesis of Insulin Resistance and Type II Diabetes
  677. Hypoxia Tolerance in Diabetes Mellitus: The Role of Fenofibrate in Facilitating Protective Metabolic reprogramming
  678. Abstract A04: Metabolic reprogramming of MYCN amplified neuroblastoma
  679. Eigenvalues of Jacobian Matrices Report on Steps of Metabolic reprogramming in a Complex Plant-Environment Interaction
  680. IMMU-37. Metabolic reprogramming OF THE GLIOMA MICROENVIRONMENT INHIBITS TUMOR IMMUNOSUPPRESSION
  681. Metabolic reprogramming underlies differential effects of folate depletion in non-metastatic and metastatic claudin-low breast cancer
  682. Metabolic reprogramming and vulnerabilities of prostate cancer stem cells independent or epithelial-mesenchymal transition
  683. Glucose Regulation of Novel Protein Complexes with Potential Roles in the Metabolic reprogramming of Human Leukemia Cells
  684. Metabolic reprogramming and miRNA expression profile in liver of prenatally dexamethasone treated rats
  685. Abstract A31: Akt-dependent Metabolic reprogramming regulates tumor cell histone acetylation
  686. Abstract A59: CHAF1A blocks neuroblastoma differentiation and promotes tumor growth via Metabolic reprogramming
  687. Adenosine Signaling Regulates Erythroid Commitment Via Modulation of Metabolic reprogramming in Stress Erythropoiesis
  688. Abstract PL03-03: The LKB1-AMPK pathway coordinates Metabolic reprogramming with growth control
  689. Metabolic reprogramming of liver cancer metabolism by the MYC oncogene
  690. Regulation of Metabolic reprogramming by MondoA and Thioredoxin Interfacing Protein
  691. Notch signaling modulates the Metabolic reprogramming to regulate MDSCs development and suppress tumor growth
  692. HIF-1-mediated Metabolic reprogramming reduces ROS levels and facilitates the metastatic colonization of breast cancers in lungs
  693. Reactive Oxygen Species Are Required For Metabolic reprogramming In Endothelial Cells Following Loss Of Laminar Shear Stress
  694. Metabolic reprogramming of Cardiac Progenitor Cells by Lin28 Enhances Cardiac Repair Potential
  695. Role of stromal fibroblasts in prostate carcinoma progression and Metabolic reprogramming of cancer cells
  696. Lineage-specific Metabolic reprogramming in BCR-ABL1-driven leukemia
  697. Crosstalk between two basic leucine ZIPPER signaling pathways orchestrates salt-induced Metabolic reprogramming in Arabidopsis roots
  698. Improper regulation of light harvesting in Arabidopsis results in a Metabolic reprogramming
  699. Lineage-Specific Metabolic reprogramming Reveals LKB1 as Therapeutic Target in Acute Lymphoblastic Leukemia
  700. Apoptosis by c-Myc: coupling Metabolic reprogramming and mitochondrial apoptosis
  701. Glutamate dehydrogenase 1 mediates Metabolic reprogramming and promotes tumor metastasis through CamKK2-AMPK signaling in LKB1-deficient lung cancer
  702. Abstract B157: Understanding the role of transcription factor ETV1 in Metabolic reprogramming of prostate cells as a route to novel therapeutics.
  703. Abstract B02: mTOR/S6K pathway-dependent Metabolic reprogramming in cancer cells mediates resistance to glycolytic inhibitors
  704. Epigenetic and Metabolic reprogramming of SDH deficient pheochromocytomas and paragangliomas
  705. Nitric Oxide: The Missing Link in Omentum-Induced Metabolic reprogramming of ovarian cancers
  706. MAP kinase inhibition induces Metabolic reprogramming in T-cells leading to induction of stem cell memory CD8 cells that enhance potency of adoptive cell therapy …
  707. Role of HIF-1α in Oncostatin M induced Metabolic reprogramming of human hepatocytes
  708. Chronic Beta2‐Adrenergic Receptor Stimulation Improves Whole‐Body Glucose Homeostasis through Skeletal Muscle Metabolic reprogramming
  709. Metabolic reprogramming and vulnerabilities of prostate cancer stem cells independent or epithelial-mesenchymal transition
  710. Nrf2 promotes oesophageal cancer cell proliferation via Metabolic reprogramming and detoxification of reactive oxygen species
  711. Sirtuin 1 mediates acidosis-induced Metabolic reprogramming of tumor cells
  712. Sirtuin 1 mediates acidosis-induced Metabolic reprogramming of tumor cells
  713. Metabolic reprogramming, cell fate decision and non-coding RNA in tumor-initiating stem-like cells
  714. Loss of Epitranscriptomic Control of Seleno-cysteine Utilization Engages Senescence and Metabolic reprogramming through mTOR Activation and Predicts Poor …
  715. Nuclear TRAF3 Inhibits CREB-mediated survival and Metabolic reprogramming in B lymphocytes (TUM10P. 1045)
  716. Abstract IA11: Targeting PI3K-mTOR signaling in glioblastoma: A central role for mTORC2 in drug resistance and Metabolic reprogramming
  717. Corrigendum: Control of amino-acid transport by antigen receptors coordinates the Metabolic reprogramming essential for T cell differentiation (Nature Immunology …
  718. Early Metabolic reprogramming in the lung after allogeneic hematopoietic cell transplantation in a murine model of GVHD
  719. Sensitivity to Romidepsin Cytotoxicity Depends on STAT3-Dependent Metabolic reprogramming of Cancer Cells
  720. Metabolic reprogramming in response to chronic acidosis regulates tumor cell protein acetylation
  721. The Mitochondrial Calcium Uniporter Modulates Macrophage Metabolic reprogramming In Pulmonary Fibrosis Development
  722. C73 OXIDANTS: Reactive Oxygen Species Are Required For Metabolic reprogramming In Endothelial Cells Following Loss Of Laminar Shear Stress
  723. A67 BREAKDOWN: THE CELLULAR CONTRIBUTION TO PULMONARY HYPERTENSION: Targeting Metabolic reprogramming In Macrophages Activated By …
  724. Extracellular Matrix Metalloproteinase Inducer (emmprin) Promotes Emt And Metabolic reprogramming In Lung Epithelial Cells
  725. Metabolic reprogramming in acute myeloid leukemia cells by mesenchymal stromal cell-derived exosomes induces chemoresistance
  726. Acute and Chronic Lymphocytic Leukemia Induces Exhaustion and Suppresses Metabolic reprogramming in T Cell Activation
  727. Phosphorus and iron deficiencies induce a Metabolic reprogramming and affect the exudation traits of the woody plant Fragariaxananassa
  728. Structural and Functional Insight of Sphingosine 1-Phosphate-Mediated Pathogenic Metabolic reprogramming in Sickle Cell Disease
  729. Pyruvate imbalance mediates Metabolic reprogramming and mimics lifespan extension by dietry restriction in Caenorhabditis elegans
  730. HDAC5 Depletion in Cancer Cells Induces an Oxidative Stress and Leads to a Metabolic reprogramming toward Glucose and Glutamine Metabolism
  731. … AND Metabolic ALTERATIONS IN LUNG DISEASE: The Mitochondrial Calcium Uniporter Modulates Macrophage Metabolic reprogramming In Pulmonary Fibrosis …
  732. Implicating the Glucagon-like peptides in the Metabolic reprogramming observed in response to Androgen Deprivation Therapy in advanced prostate cancer …
  733. Adipocytes-mediated autophagy activation and Metabolic reprogramming promotes colon cancer survival
  734. Fibroblast Generated Extracellular Vesicles Induces Pro-Inflammatory and Metabolic reprogramming in Bone Marrow Derived Macrophages
  735. Through Metabolic reprogramming Walnut May Mitigate the Stemness of Colon Cancer Stem Cells
  736. Metabolic reprogramming of Mesenchymal Stem Cells upon Co-Cultivation with Primary CLL Cells Determined By Mass Spectrometry-Based Proteomics
  737. Indoleamine 2, 3-dioxygenase regulates anti-tumor immunity in lung cancer by Metabolic reprogramming of immune cells
  738. Differential effects of folate depletion on Metabolic reprogramming and oxidative stress in nonmetastatic and metastatic claudin-low breast cancer cells
  739. Complex I Mitochondrial Dysfunction in HDAC5-depleted Cancer Cells Induces Glucose-dependent Metabolic reprogramming
  740. Network biology approaches reveal a link between ribosome biogenesis and Metabolic reprogramming in ageing skeletal muscles
  741. Human Double-Negative Regulatory T Cells Selectively Suppress mTOR Signaling and Metabolic reprogramming of Conventional T Cells
  742. Metabolic reprogramming of CD4 T cells exacerbates Herpes Stromal Keratitis
  743. Glucose Promotes Metabolic reprogramming of Male Rat Hearts in the Early Stress Response Following Hypothermic Ischemic Arrest and Reperfusion
  744. Arginine Deiminase Resistance in Melanoma Cells Is Associated with Metabolic reprogramming, Glucose Dependence and Glutamine Addiction
  745. Sodium borate treatment induces Metabolic reprogramming in hepatocellular carcinoma through SIRT3 activation
  746. B53 PHOUND IN TRANSLATION: Using Genetics, Epigenetics And Small Molecules To Reverse Metabolic reprogramming In Adventitia Fibroblasts For Pulmonary …
  747. Regulation of CD8+ T cell differentiation and Metabolic reprogramming by the T cell receptor dependent transcription factor IRF4
  748. The emerging role of thioredoxin-1 on ROS and Metabolic reprogramming in cisplatin resistant lung cancer
  749. … : CURRENT AND FUTURE APPROACHES: Extracellular Matrix Metalloproteinase Inducer (emmprin) Promotes Emt And Metabolic reprogramming In Lung Epithelial …
  750. Selective regulation of macrophages differentiation and function by mTOR and Metabolic reprogramming: mTORC2 regulates peritoneal tissue-resident macrophages …
  751. … Stretch Combines With Adventitial Fibroblast-Derived Signals To Promote Macrophage Activation Through Metabolic reprogramming In Vascular Remodeling
  752. Adenylate kinase 4 promotes Metabolic reprogramming and induces EMT in lung cancer through ROS-dependent stabilization of HIF1-α
  753. Interferons: reprogramming the Metabolic network against viral infection
  754. Epigenetic reprogramming in Metabolic disorders: nutritional factors and beyond
  755. Deletion of the mitochondrial chaperone TRAP-1 uncovers global reprogramming of Metabolic networks
  756. Indolamine-2, 3-Dioxygenase in Myeloid-Derived Suppressor Cells Alters Mitochondrial Dynamics and Mediates Metabolic reprogramming in the Tumor …
  757. Identification and successful negotiation of a Metabolic checkpoint in direct neuronal reprogramming
  758. Functional reprogramming Of Macrophages Through Targeted Inhibition Of Metabolic Pathways As A Strategy To Promote Anti-Inflammatory Signaling In Pulmonary …
  759. Circadian reprogramming in the liver identifies Metabolic pathways of aging
  760. Mitochondrial and Metabolic remodeling during reprogramming and differentiation of the reprogrammed cells
  761. Stem cell Metabolic and epigenetic reprogramming
  762. Paternally induced transgenerational environmental reprogramming of Metabolic gene expression in mammals
  763. Muscle ERRγ mitigates Duchenne muscular dystrophy via Metabolic and angiogenic reprogramming
  764. Maternal diet, bioactive molecules, and exercising as reprogramming tools of Metabolic programming
  765. The metabolome of induced pluripotent stem cells reveals Metabolic changes occurring in somatic cell reprogramming
  766. Hallmarks in Colorectal Cancer: reprogramming of Metabolic Pathways and Cancer Stem-Like Cells
  767. Activation of AMP-activated protein kinase (AMPK) provides a Metabolic barrier to reprogramming somatic cells into stem cells
  768. Skeletal muscle reprogramming by activation of calcineurin improves insulin action on Metabolic pathways
  769. Role of hypothalamic creb-binding protein in obesity and molecular reprogramming of Metabolic substrates
  770. Abstract P5-03-05: Histone deacetylase (HDAC)-inhibitor mediated reprogramming drives cancer cells to the pentose phosphate Metabolic pathway
  771. Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors
  772. Nuclear reprogramming: kinetics of cell cycle and Metabolic progression as determinants of success
  773. reprogramming the cancer epigenome by “Metabolic transduction”
  774. Insights from the cold transcriptome and metabolome of Dendrobium officinale: global reprogramming of Metabolic and gene regulation networks during cold …
  775. Metabolomics reveals comprehensive reprogramming involving two independent Metabolic responses of Arabidopsis to UV‐B light
  776. reprogramming of Th1 cells into regulatory T cells through rewiring of the Metabolic status
  777. Transcriptome reprogramming during severe dehydration contributes to physiological and Metabolic changes in the resurrection plant Haberlea rhodopensis
  778. Polyamine oxidase 5 loss‐of‐function mutations in Arabidopsis thaliana trigger Metabolic and transcriptional reprogramming and promote salt stress tolerance
  779. Hodgkin lymphoma: A complex Metabolic ecosystem with glycolytic reprogramming of the tumor microenvironment
  780. Developmental origin of reproductive and Metabolic dysfunctions: androgenic versus estrogenic reprogramming
  781. Involvement of the IRE1α-XBP1 pathway and XBP1s-dependent transcriptional reprogramming in Metabolic diseases
  782. An inflammatory-CCRK circuitry drives mTORC1-dependent Metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular …
  783. Developmental reprogramming of reproductive and Metabolic dysfunction in sheep: native steroids vs. environmental steroid receptor modulators
  784. Metabolic profiling reveals reprogramming of lipid Metabolic pathways in treatment of polycystic ovary syndrome with 3‐iodothyronamine
  785. reprogramming Metabolic flux in glioma
  786. Metabolic flux redirection and transcriptomic reprogramming in the albino tea cultivar ‘Yu-Jin-Xiang’with an emphasis on catechin production
  787. Epigenetic, post-transcriptional and Metabolic mechanisms of macrophage reprogramming
  788. OP0211 reprogramming of Metabolic Pathways Inhibits TLR2-Induced Inflammation in RA
  789. Molecular mechanisms governing contraction-induced Metabolic responses and skeletal muscle reprogramming
  790. reprogramming One-Carbon Metabolic Pathways To Decouple l-Serine Catabolism from Cell Growth in Corynebacterium glutamicum
  791. Role of Glutamine in Metabolic and Epigenetic reprogramming in AML
  792. Abstract A07: Inhibiting radiation-induced reprogramming of breast cancer cells via Metabolic perturbation
  793. … /p62-Nrf2 pathway activation mediates proteasome inhibitor resistance in multiple myeloma cells via redox, Metabolic and translational reprogramming
  794. reprogramming the glycolytic pathway for increased hydrogen production in cyanobacteria: Metabolic engineering of NAD+-dependent GAPDH
  795. The mevalonate pathway drives Metabolic and epigenetic reprogramming during induction of trained immunity
  796. Metabolic Profiling Reveals reprogramming of Lipid Metabolic Pathways in Treatment of Polycystic Ovary Syndrome with 3‐Iodothyronamine
  797. Development of a novel plasmid-free thymidine producer by reprogramming nucleotide Metabolic pathways
  798. Mitochondrial physiology and gene expression analyses reveal Metabolic and translational dysregulation in oocyte-induced somatic nuclear reprogramming
  799. eIF4E phosphorylation licenses Myc-driven Metabolic and stress reprogramming
  800. Transcriptional reprogramming of pancreatic stroma induces Metabolic changes in pancreatic tumor cells
  801. Abstract B48: Epigenetic reprogramming of mitochondrial and Metabolic functions plays a key role in arginine-deprivation based cancer therapy
  802. Metabolome Dynamics Platform Reveals Endocrine‐Metabolic Crosstalk in PCOS and Its reprogramming of Lipid Metabolic Pathways with 3‐Iodothyronamine
  803. … serum metabolomics analyses uncover that Total Glucosides of Paeony protect liver against acute injury potentially via reprogramming of multiple Metabolic …
  804. A Novel Caloric Restriction-Like Mimetic Affects Longevity in Yeast by reprogramming Core Metabolic Pathways
  805. Ancestral obesity and early life Metabolic dysfunction accelerates acinar-to-ductal reprogramming and PanIN/PDAC development in the P48Cre/+/KrasG120/+ mouse …
  806. Lysine-specific histone demethylase 1 inhibition promotes reprogramming by facilitating the expression of exogenous transcriptional factors and Metabolic …
  807. PO-267 PHGDH and PSAT confer Metabolic vulnerability to IDH2-driven reprogramming in breast cancer
  808. 25 reprogramming of Metabolic systems by altering gene expression
  809. A1. 07 reprogramming of Metabolic pathways inhibits TLR2-induced inflammation in ra
  810. Redox Regulation of MKP-1 and the Functional reprogramming of Monocyte-Derived Macrophages by Metabolic Stress
  811. Polyamine oxidase 5 lossâ ofâ function mutations in Arabidopsis thaliana trigger Metabolic and transcriptional reprogramming and promote salt stress tolerance
  812. 2559 Role of Glutamine in Metabolic and Epigenetic reprogramming in AML
  813. Metabolic reprogramming and cancer progression
  814. Metabolic reprogramming in breast cancer and its therapeutic implications
  815. Phage-specific Metabolic reprogramming of virocells
  816. The ERK and JNK pathways in the regulation of Metabolic reprogramming
  817. Metabolic reprogramming in triple-negative breast cancer
  818. New insights on the role of lipid metabolism in the Metabolic reprogramming of macrophages
  819. Metabolic reprogramming in immune response and tissue inflammation
  820. Metabolic reprogramming and disease progression in cancer patients
  821. Itaconate: the poster child of Metabolic reprogramming in macrophage function
  822. The roles of glucose Metabolic reprogramming in chemo-and radio-resistance
  823. The role of Wnt signaling pathway in tumor Metabolic reprogramming
  824. Metabolic reprogramming in osteoclasts
  825. The Warburg effect: essential part of Metabolic reprogramming and central contributor to cancer progression
  826. Nitric oxide and tumor Metabolic reprogramming
  827. Metabolic reprogramming of macrophages during infections and cancer
  828. Macrophage Metabolic reprogramming during chronic lung disease
  829. A breakdown in Metabolic reprogramming causes microglia dysfunction in Alzheimer’s disease
  830. Metabolic reprogramming in the pathogenesis of glioma: Update
  831. Metabolic reprogramming in cancer is induced to increase proton production
  832. Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
  833. A variant of SLC1A5 is a mitochondrial glutamine transporter for Metabolic reprogramming in cancer cells
  834. DNA damage response and Metabolic reprogramming in health and disease
  835. Role of purines in regulation of Metabolic reprogramming
  836. Role of Metabolic reprogramming in epithelial–mesenchymal transition (EMT)
  837. Cancer cell Metabolic reprogramming: a keystone for the response to immunotherapy
  838. Targeting Metabolic reprogramming in acute myeloid leukemia
  839. Metabolic reprogramming of host cells in response to enteroviral infection
  840. Metabolic reprogramming as a key regulator in the pathogenesis of rheumatoid arthritis
  841. ITGB4-mediated Metabolic reprogramming of cancer-associated fibroblasts
  842. Metabolic reprogramming results in abnormal glycolysis in gastric cancer: a review
  843. Long non-coding RNAs involved in cancer Metabolic reprogramming
  844. Metabolic reprogramming in mitochondria of myeloid cells
  845. Role of Metabolic reprogramming in pulmonary innate immunity and its impact on lung diseases
  846. Emerging role of Metabolic reprogramming in tumor immune evasion and immunotherapy
  847. Tobacco smoking induces Metabolic reprogramming of renal cell carcinoma
  848. Metabolic reprogramming toward oxidative phosphorylation identifies a therapeutic target for mantle cell lymphoma
  849. Metabolic reprogramming of chemoresistant cancer cells and the potential significance of Metabolic regulation in the reversal of cancer chemoresistance
  850. Cellular Metabolic reprogramming controls sugar appetite in Drosophila
  851. A regulator of Metabolic reprogramming: MicroRNA Let-7
  852. Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury
  853. Metabolic reprogramming in triple-negative breast cancer
  854. Metabolic reprogramming in prostate cancer
  855. Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance
  856. Redox tolerance and Metabolic reprogramming in solid tumors
  857. Metabolic reprogramming of cancer cells during tumor progression and metastasis
  858. Exosome-mediated Metabolic reprogramming: the emerging role in tumor microenvironment remodeling and its influence on cancer progression
  859. Venetoclax causes Metabolic reprogramming independent of BCL-2 inhibition
  860. Lipid Metabolic reprogramming: role in melanoma progression and therapeutic perspectives
  861. MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose Metabolic reprogramming
  862. Hypoxia‐inducible factors in Metabolic reprogramming during sepsis
  863. Metabolic reprogramming of the host cell by human adenovirus infection
  864. Metabolic reprogramming: an innate cellular defence mechanism against intracellular bacteria?
  865. Metabolic reprogramming and the role of mitochondria in polycystic kidney disease
  866. Prolyl isomerase Pin1 in Metabolic reprogramming of cancer cells
  867. Hypoxia-and microRNA-induced Metabolic reprogramming of tumor-initiating cells
  868. Single-cell analysis uncovers that Metabolic reprogramming by ErbB2 signaling is essential for cardiomyocyte proliferation in the regenerating heart
  869. EGFL9 promotes breast cancer metastasis by inducing cMET activation and Metabolic reprogramming
  870. Involvement of FATP2-mediated tubular lipid Metabolic reprogramming in renal fibrogenesis
  871. Metabolic reprogramming in Anticancer Drug Resistance: A Focus on Amino Acids
  872. Metabolic reprogramming in astrocytes distinguishes region-specific neuronal susceptibility in Huntington mice
  873. Mitochondrial CaMKII causes adverse Metabolic reprogramming and dilated cardiomyopathy
  874. ITLN1 modulates invasive potential and Metabolic reprogramming of ovarian cancer cells in omental microenvironment
  875. Intracellular transport in cancer Metabolic reprogramming
  876. Compromised Metabolic reprogramming is an early indicator of CD8+ T cell dysfunction during chronic Mycobacterium tuberculosis infection
  877. MTHFD2 links RNA methylation to Metabolic reprogramming in renal cell carcinoma
  878. Mitochondria dysfunction and Metabolic reprogramming as drivers of idiopathic pulmonary fibrosis
  879. Metabolic reprogramming and epithelial-mesenchymal plasticity: opportunities and challenges for cancer therapy
  880. Effect of PTEN loss on Metabolic reprogramming in prostate cancer cells
  881. Oncogenic KRAS-driven Metabolic reprogramming in pancreatic cancer cells utilizes cytokines from the tumor microenvironment
  882. Metabolic reprogramming promotes neural crest migration via yap/tead signaling
  883. Macrophage Metabolic reprogramming presents a therapeutic target in lupus nephritis
  884. Enhancing salt tolerance of plants: From Metabolic reprogramming to exogenous chemical treatments and molecular approaches
  885. A unique morphological phenotype in chemoresistant triple-negative breast cancer reveals Metabolic reprogramming and PLIN4 expression as a molecular …
  886. Cardamonin inhibits breast cancer growth by repressing HIF-1α-dependent Metabolic reprogramming
  887. STAT3 serine phosphorylation is required for TLR4 Metabolic reprogramming and IL-1β expression
  888. Monocyte Metabolic reprogramming promotes pro-inflammatory activity and Staphylococcus aureus biofilm clearance
  889. Untangling the Metabolic reprogramming in brain cancer: discovering key molecular players using mass spectrometry
  890. Metabolic reprogramming by Zika virus provokes inflammation in human placenta
  891. Metabolic reprogramming and Notch activity distinguish between non-small cell lung cancer subtypes
  892. YY 1 regulates skeletal muscle regeneration through controlling Metabolic reprogramming of satellite cells
  893. Integrating Metabolic reprogramming and Metabolic imaging to predict breast cancer therapeutic responses
  894. Metabolic reprogramming and epigenetic changes of vital organs in SARS-CoV-2–induced systemic toxicity
  895. Metabolic reprogramming as a driver of fibroblast activation in PulmonaryFibrosis
  896. Metabolic reprogramming in renal cancer: Events of a Metabolic disease
  897. Metabolic reprogramming: A friend or foe to cancer therapy?
  898. Metabolic reprogramming of donor T cells enhances graft-versus-leukemia effects in mice and humans
  899. Erythrocyte adaptive Metabolic reprogramming under physiological and pathological hypoxia
  900. Modern perspective on Metabolic reprogramming in malignant neoplasms
  901. Cisplatin resistance involves a Metabolic reprogramming through ROS and PGC-1α in NSCLC which can be overcome by OXPHOS inhibition
  902. Mitochondrial Metabolic reprogramming: An important player in liver cancer progression
  903. The Metabolic reprogramming in acute myeloid leukemia patients depends on their genotype and is a prognostic marker
  904. Metabolic reprogramming and its clinical application in thyroid cancer
  905. HIF1α‐dependent Metabolic reprogramming governs mesenchymal stem/stromal cell immunoregulatory functions
  906. Skeletal-muscle Metabolic reprogramming in ALS-SOD1G93A mice predates disease onset and is a promising therapeutic target
  907. Retrodifferentiation of human tumor hepatocytes to stem cells leads to Metabolic reprogramming and chemoresistance
  908. Lipid Metabolic reprogramming as an emerging mechanism of resistance to kinase inhibitors in breast cancer
  909. ER-residential Nogo-B accelerates NAFLD-associated HCC mediated by Metabolic reprogramming of oxLDL lipophagy
  910. Hydrogen sulfide perturbs mitochondrial bioenergetics and triggers Metabolic reprogramming in colon cells
  911. SNHG3 functions as miRNA sponge to promote breast cancer cells growth through the Metabolic reprogramming
  912. The complement system drives local inflammatory tissue priming by Metabolic reprogramming of synovial fibroblasts
  913. Exploiting KRAS-mediated Metabolic reprogramming as a therapeutic target
  914. Metabolic reprogramming in autosomal dominant polycystic kidney disease: evidence and therapeutic potential
  915. SQSTM1/p62-directed Metabolic reprogramming is essential for normal neurodifferentiation
  916. Mutations in NDUFS1 cause Metabolic reprogramming and disruption of the electron transfer
  917. Preservation of microvascular barrier function requires CD31 receptor-induced Metabolic reprogramming
  918. miR-142 controls Metabolic reprogramming that regulates dendritic cell activation
  919. OXPHOS-dependent Metabolic reprogramming prompts metastatic potential of breast cancer cells under osteogenic differentiation
  920. G6PD: a hub for Metabolic reprogramming and redox signaling in cancer
  921. Metabolomics deciphered Metabolic reprogramming required for biofilm formation
  922. mTOR‐mediated Metabolic reprogramming shapes distinct microglia functions in response to lipopolysaccharide and ATP
  923. Platelets facilitate the wound-healing capability of mesenchymal stem cells by mitochondrial transfer and Metabolic reprogramming
  924. Metabolic reprogramming in memory CD4 T cell responses of old adults
  925. Targeting Metabolic reprogramming in metastatic melanoma: the key role of nicotinamide phosphoribosyltransferase (NAMPT)
  926. … pathways are associated with disease activity in rheumatoid arthritis and are subject to disease modification through Metabolic reprogramming: a potential novel …
  927. Branched-chain amino acid Metabolic reprogramming orchestrates drug resistance to EGFR tyrosine kinase inhibitors
  928. Modulation of mitochondrial Metabolic reprogramming and oxidative stress to overcome chemoresistance in cancer
  929. Autonomous glucose Metabolic reprogramming of tumour cells under hypoxia: opportunities for targeted therapy
  930. In-situ generation of large numbers of genetic combinations for Metabolic reprogramming via CRISPR-guided base editing
  931. Mechanisms modulating anoikis resistance in cancer and the relevance of Metabolic reprogramming
  932. Mitochondrial Metabolic reprogramming by CD36 signaling drives macrophage inflammatory responses
  933. Concealed Metabolic reprogramming induced by different herbicides in tomato
  934. Targeted Metabolic reprogramming to improve the efficacy of oncolytic virus therapy
  935. Beyond the Warburg effect: N-Myc contributes to Metabolic reprogramming in cancer cells
  936. Metabolic reprogramming in Cancer: Role of HPV 16 Variants
  937. Acetyl-CoA carboxylase inhibition disrupts Metabolic reprogramming during hepatic stellate cell activation
  938. Selenium deficiency-induced redox imbalance leads to Metabolic reprogramming and inflammation in the liver
  939. Curcumin and its potential for systemic targeting of inflamm-aging and Metabolic reprogramming in cancer
  940. Mechanistic insights into bacterial Metabolic reprogramming from omics-integrated genome-scale models
  941. Lactylation, a Novel Metabolic reprogramming Code: Current Status and Prospects
  942. CA IX stabilizes intracellular pH to maintain Metabolic reprogramming and proliferation in hypoxia
  943. PDK4 promotes vascular calcification by interfering with autophagic activity and Metabolic reprogramming
  944. Metabolic reprogramming and reactive oxygen species in T cell immunity
  945. Androgen-induced expression of DRP1 regulates mitochondrial Metabolic reprogramming in prostate cancer
  946. Epigenetic and Metabolic reprogramming of SDH-deficient paragangliomas
  947. Linking Immunoevasion and Metabolic reprogramming in B-Cell–Derived Lymphomas
  948. Differential Metabolic reprogramming by Zika virus promotes cell death in human versus mosquito cells
  949. Lead exposure induces Metabolic reprogramming in rat models
  950. GTP Metabolic reprogramming by IMPDH2: Unlocking cancer cells’ fuelling mechanism
  951. Anti‐inflammatory and Metabolic reprogramming effects of MENK produce antitumor response in CT26 tumor‐bearing mice
  952. The complex interplay between Metabolic reprogramming and epigenetic alterations in renal cell carcinoma
  953. Interleukin 6-independent Metabolic reprogramming as a driver of cancer-related fatigue
  954. Metabolic reprogramming and Predominance of Solute Carrier Genes during Acquired Enzalutamide Resistance in Prostate Cancer
  955. Hyperactivity of the transcription factor Nrf2 causes Metabolic reprogramming in mouse esophagus
  956. Linking Metabolic reprogramming, Plasticity and Tumor Progression
  957. Role of bladder cancer Metabolic reprogramming in the effectiveness of immunotherapy
  958. Warburg-like Metabolic reprogramming in aging intestinal stem cells contributes to tissue hyperplasia
  959. Hotspot SF3B1 mutations induce Metabolic reprogramming and vulnerability to serine deprivation
  960. Metabolic reprogramming of cancer by chemicals that target glutaminase isoenzymes
  961. Metabolic reprogramming induces immune cell dysfunction in the tumor microenvironment of multiple myeloma
  962. MiR‐9‐5p protects from kidney fibrosis by Metabolic reprogramming
  963. Thyroid hormone inhibits hepatocellular carcinoma progression via induction of differentiation and Metabolic reprogramming
  964. Polyunsaturated fatty acids and p38-MAPK link Metabolic reprogramming to cytoprotective gene expression during dietary restriction
  965. Erythrocyte Metabolic reprogramming by sphingosine 1-phosphate in chronic kidney disease and therapies
  966. Distinct cell-types in the prostate share an aging signature suggestive of Metabolic reprogramming
  967. IgG subclasses shape cytokine responses by human myeloid immune cells through differential Metabolic reprogramming
  968. Metabolic reprogramming‐associated genes predict overall survival for rectal cancer
  969. CaMeRe: A Novel Tool for Inference of Cancer Metabolic reprogramming
  970. miR-27a is a master regulator of Metabolic reprogramming and chemoresistance in colorectal cancer
  971. Endothelial-to-mesenchymal transition compromises vascular integrity to induce Myc-mediated Metabolic reprogramming in kidney fibrosis
  972. Multi-omics analysis identifies FoxO1 as a regulator of macrophage function through Metabolic reprogramming
  973. Label-free sensing of exosomal MCT1 and CD147 for tracking Metabolic reprogramming and malignant progression in glioma
  974. β-Adrenergic signaling blocks murine CD8+ T-cell Metabolic reprogramming during activation: a mechanism for immunosuppression by adrenergic stress
  975. COX6B2 drives Metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells
  976. Her4 promotes cancer Metabolic reprogramming via the c-Myc-dependent signaling axis
  977. LKB1 and KEAP1/NRF2 pathways cooperatively promote Metabolic reprogramming with enhanced glutamine dependence in KRAS-mutant lung adenocarcinoma
  978. Macrophage Metabolic reprogramming aggravates aortic dissection through the HIF1α-ADAM17 pathway✰
  979. Nrf2 and HIF1α converge to arsenic-induced Metabolic reprogramming and the formation of the cancer stem-like cells
  980. Glucose Metabolic reprogramming of ER breast cancer in acquired resistance to the CDK4/6 inhibitor palbociclib+
  981. Metabolic reprogramming in breast cancer results in distinct mitochondrial bioenergetics between luminal and basal subtypes
  982. Immune-mediated anti-tumor effects of metformin; targeting Metabolic reprogramming of T cells as a new possible mechanism for anti-cancer effects of metformin
  983. Metabolomics study reveals the potential evidence of Metabolic reprogramming towards the Warburg effect in precancerous lesions
  984. BCR-induced Ca2+ signals dynamically tune survival, Metabolic reprogramming, and proliferation of naive B cells
  985. … complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain Metabolic reprogramming in male mice
  986. PKCλ/ι loss induces Metabolic reprogramming in liver cancer: hitting two birds with one stone?
  987. Metabolic reprogramming by MYCN confers dependence on the serine-glycine-one-carbon biosynthetic pathway
  988. Metabolic reprogramming in CD8+ T cells during acute viral infections
  989. TGF-β promotes Metabolic reprogramming in lung fibroblasts via mTORC1-dependent ATF4 activation
  990. Lipoxygenase drives lipidomic and Metabolic reprogramming in ischemic heart failure
  991. Multi-omics studies demonstrate toxoplasma gondii-induced Metabolic reprogramming of murine dendritic cells
  992. Metabolic reprogramming associated with aggressiveness occurs in the G-CIMP-high molecular subtypes of IDH1mut lower grade gliomas
  993. HDAC inhibitors elicit Metabolic reprogramming by targeting super-enhancers in glioblastoma models
  994. Metabolic reprogramming of ovarian cancer involves ACSL1-mediated metastasis stimulation through upregulated protein myristoylation
  995. Metformin induces CD11b+-cell-mediated growth inhibition of an osteosarcoma: implications for Metabolic reprogramming of myeloid cells and anti-tumor effects
  996. 6PGD inhibition sensitizes hepatocellular carcinoma to chemotherapy via AMPK activation and Metabolic reprogramming
  997. Mitochondrial calcium uniporter regulates PGC-1α expression to mediate Metabolic reprogramming in pulmonary fibrosis
  998. Metabolic reprogramming dynamics in tumor spheroids: Insights from a multicellular, multiscale model
  999. MET inhibition elicits PGC1α-dependent Metabolic reprogramming in glioblastoma
  1000. Untargeted metabolomics reveal defensome-related Metabolic reprogramming in Sorghum bicolor against infection by Burkholderia andropogonis
  1001. Lysine methyltransferase 2D regulates pancreatic carcinogenesis through Metabolic reprogramming
  1002. Metabolic reprogramming by N‐acetyl‐seryl‐aspartyl‐lysyl‐proline protects against diabetic kidney disease
  1003. Metabolic reprogramming of trophoblast cells in response to hypoxia
  1004. Toll‐like receptor 2 regulates Metabolic reprogramming in gastric cancer via superoxide dismutase 2
  1005. Loss of PTEN expression is associated with PI3K pathway-dependent Metabolic reprogramming in hepatocellular carcinoma
  1006. Metabolic reprogramming by Malat1 Depletion in Prostate Cancer
  1007. Dual Metabolic reprogramming by ONC201/TIC10 and 2-Deoxyglucose induces energy depletion and synergistic anti-cancer activity in glioblastoma
  1008. Cancer Metabostemness and Metabolic reprogramming via P2X7 Receptor
  1009. Macrophage miR-210 induction and Metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation
  1010. FRK plays an oncogenic role in non‐small cell lung cancer by enhancing the stemness phenotype via induction of Metabolic reprogramming
  1011. Suppression of p16 induces mTORC1-mediated nucleotide Metabolic reprogramming
  1012. Metabolic reprogramming of osteoclasts represents a therapeutic target during the treatment of osteoporosis
  1013. Nuclear-encoded lncRNA MALAT1 epigenetically controls Metabolic reprogramming in HCC cells through the mitophagy pathway
  1014. Gankyrin drives Metabolic reprogramming to promote tumorigenesis, metastasis and drug resistance through activating β-catenin/c-Myc signaling in human …
  1015. The role of Metabolic reprogramming in tubular epithelial cells during the progression of acute kidney injury
  1016. Fueling influenza and the immune response: Implications for Metabolic reprogramming during influenza infection and immunometabolism
  1017. Metabolic reprogramming in atherosclerosis: opposed interplay between the canonical WNT/β-catenin pathway and PPARγ
  1018. Metabolic reprogramming in nodules, roots, and leaves of symbiotic soybean in response to iron deficiency
  1019. Adaptation of human iPSC-derived cardiomyocytes to tyrosine kinase inhibitors reduces acute cardiotoxicity via Metabolic reprogramming
  1020. Host Metabolic reprogramming in response to SARS-Cov-2 infection
  1021. Screening of Metabolic modulators identifies new strategies to target Metabolic reprogramming in melanoma
  1022. p53 Promotes chemoresponsiveness by regulating hexokinase II gene transcription and Metabolic reprogramming in epithelial ovarian cancer
  1023. Role of pyruvate kinase M2-mediated Metabolic reprogramming during podocyte differentiation
  1024. Role of dendritic cell Metabolic reprogramming in tumor immune evasion
  1025. The choice of tissue fixative is a key determinant for mass spectrometry imaging based tumor Metabolic reprogramming characterization
  1026. Metabolic reprogramming of cancer-associated fibroblasts and its effect on cancer cell reprogramming
  1027. Metabolic reprogramming of the myeloid lineage by Schistosoma mansoni infection persists independently of antigen exposure
  1028. Metabolic reprogramming and vulnerabilities in cancer
  1029. Metabolic reprogramming during microglia activation
  1030. Metabolic reprogramming sustains cancer cell survival following extracellular matrix detachment
  1031. Metabolic reprogramming of glycolysis and glutamine metabolism are key events in myofibroblast transition in systemic sclerosis pathogenesis
  1032. Caveolin-1 inhibits breast cancer stem cells via c-Myc-mediated Metabolic reprogramming
  1033. Metabolic reprogramming: A driver of cigarette smoke-induced inflammatory lung diseases
  1034. Reversed Metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model
  1035. CdS nanoparticles in soil induce Metabolic reprogramming in broad bean (Vicia faba L.) roots and leaves
  1036. Gut cytokines modulate olfaction through Metabolic reprogramming of glia
  1037. Multiomics Analysis and Systems Biology Integration Identifies the Roles of IL-9 in Keratinocyte Metabolic reprogramming
  1038. Prognostic roles of Metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
  1039. Virus-induced Metabolic reprogramming and innate sensing hereof by the infected host
  1040. Alum impairs tolerogenic properties induced by allergoid‐mannan conjugates inhibiting mTOR and Metabolic reprogramming in human DCs
  1041. A cancer ubiquitome landscape identifies Metabolic reprogramming as target of Parkin tumor suppression
  1042. Diabetes mellitus type 2 drives Metabolic reprogramming to promote pancreatic cancer growth
  1043. Non-coding RNAs operate in the crosstalk between cancer Metabolic reprogramming and metastasis
  1044. Super-enhancer-driven Metabolic reprogramming promotes cystogenesis in autosomal dominant polycystic kidney disease
  1045. Targeting hypoxia-driven Metabolic reprogramming to constrain tumor progression and metastasis
  1046. Metabolomics profiling of metformin-mediated Metabolic reprogramming bypassing AMPKα
  1047. Metabolic reprogramming of normal oral fibroblasts correlated with increased glycolytic metabolism of oral squamous cell carcinoma and precedes their activation into …
  1048. Macrophage origin, Metabolic reprogramming and IL-1β signaling: Promises and pitfalls in lung cancer
  1049. Materials Stiffness‐Dependent Redox Metabolic reprogramming of Mesenchymal Stem Cells for Secretome‐Based Therapeutic Angiogenesis
  1050. Metabolic reprogramming by traditional Chinese medicine and its role in effective cancer therapy
  1051. Hypoxia-induced GBE1 expression promotes tumor progression through Metabolic reprogramming in lung adenocarcinoma
  1052. Doxorubicin‐induced cardiotoxicity involves IFNγ‐mediated Metabolic reprogramming in cardiomyocytes
  1053. The Metabolic reprogramming induced by sub-optimal nutritional and light inputs in soilless cultivated green and red butterhead lettuce
  1054. Mitochondrial Metabolic reprogramming controls the induction of immunogenic cell death and efficacy of chemotherapy in bladder cancer
  1055. Metabolic reprogramming in the opportunistic yeast Candida albicans in response to hypoxia
  1056. Tissue-infiltrating macrophages mediate an exosome-based Metabolic reprogramming upon DNA damage
  1057. Metabolic reprogramming of terminally exhausted CD8+ T cells by IL-10 enhances anti-tumor immunity
  1058. Insulin receptor isoform A modulates Metabolic reprogramming of breast cancer cells in response to IGF2 and insulin stimulation
  1059. Metabolomics analysis reveals deranged energy metabolism and amino acid Metabolic reprogramming in dogs with myxomatous mitral valve disease
  1060. Metabolic reprogramming of Vascular Endothelial Cells: Basic Research and Clinical Applications
  1061. Metabolic reprogramming of fibro/adipogenic progenitors facilitates muscle regeneration
  1062. … of toll-like receptor 4 mitigates obesity-induced oxidative stress, proinflammation, and insulin resistance through Metabolic reprogramming of mitochondria in adipose …
  1063. Epigenetic Metabolic reprogramming of right ventricular fibroblasts in pulmonary arterial hypertension: a pyruvate dehydrogenase kinase-dependent shift in …
  1064. Circular RNA: The main regulator of energy Metabolic reprogramming in cancer cells
  1065. Metabolic reprogramming in metastatic melanoma with acquired resistance to targeted therapies: Integrative metabolomic and proteomic analysis
  1066. LKB1 deficiency-induced Metabolic reprogramming in tumorigenesis and non-neoplastic diseases
  1067. Hypoxia, Metabolic reprogramming, and Drug Resistance in Liver Cancer
  1068. Changes in the turnover of the cellular proteome during Metabolic reprogramming: A role for mtROS in proteostasis
  1069. Metabolic reprogramming promotes myogenesis during aging
  1070. Photoreceptor Metabolic reprogramming: current understanding and therapeutic implications
  1071. Research Progress of TXNIP as a Tumor Suppressor Gene Participating in the Metabolic reprogramming and Oxidative Stress of Cancer Cells in Various …
  1072. Insights on Metabolic reprogramming and Its Therapeutic Potential in Acute Leukemia
  1073. Chronic exposure to chewing tobacco induces Metabolic reprogramming and cancer stem cell-like properties in esophageal epithelial cells
  1074. Snail-overexpression induces epithelial-mesenchymal transition and Metabolic reprogramming in human pancreatic ductal adenocarcinoma and non-tumorigenic …
  1075. Tumor Metabolic reprogramming by Adipokines as a Critical Driver of Obesity-Associated Cancer Progression
  1076. Cigarette smoke induces Metabolic reprogramming of the tumor stroma in head and neck squamous cell carcinoma
  1077. Inhibition of 2-hydroxyglutarate elicits Metabolic reprogramming and mutant IDH1 glioma immunity in mice
  1078. Biological role of Metabolic reprogramming of cancer cells during epithelial‑mesenchymal transition
  1079. TLR-2-mediated Metabolic reprogramming participates in polyene phosphatidylcholine-mediated inhibition of M1 macrophage polarization
  1080. Metabolic reprogramming in cancer: mechanistic insights from Drosophila
  1081. Epigenetic mechanisms and Metabolic reprogramming in fibrogenesis: dual targeting of G9a and DNMT1 for the inhibition of liver fibrosis
  1082. MIG‐6 is essential for promoting glucose Metabolic reprogramming and tumor growth in triple‐negative breast cancer
  1083. … spectrometry-based metabolomics reveals the mechanism of ambient fine particulate matter and its components on energy Metabolic reprogramming in BEAS-2B …
  1084. Autophagy activation and SREBP‐1 induction contribute to fatty acid Metabolic reprogramming by leptin in breast cancer cells
  1085. Fenofibrate-induced mitochondrial dysfunction and Metabolic reprogramming reversal: the anti-tumor effects in gastric carcinoma cells mediated by the PPAR …
  1086. Metabolic reprogramming by tobacco-specific nitrosamines (TSNAs) in cancer
  1087. Metabolomic and transcriptional analyses reveal atmospheric oxygen during human induced pluripotent stem cell generation impairs Metabolic reprogramming
  1088. Dynamic Metabolic reprogramming in dendritic cells: An early response to influenza infection that is essential for effector function
  1089. Metabolic reprogramming Induces Germinal Center B Cell Differentiation through Bcl6 Locus Remodeling
  1090. Mechanisms by which Metabolic reprogramming in GSD1 liver generates a favorable tumorigenic environment
  1091. The effects of dietary methionine restriction on the function and Metabolic reprogramming in the liver and brain–implications for longevity
  1092. Metabolic reprogramming—A New Era How to Prevent and Treat Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation Has …
  1093. The SIRT2/cMYC pathway inhibits peroxidation-related apoptosis in cholangiocarcinoma through Metabolic reprogramming
  1094. Kinetic modelling of quantitative proteome data predicts Metabolic reprogramming of liver cancer
  1095. EBV (LMP1)-induced Metabolic reprogramming inhibits necroptosis through the hypermethylation of the RIP3 promoter
  1096. Mitophagy protein PINK1 suppresses colon tumor growth by Metabolic reprogramming via p53 activation and reducing acetyl-CoA production
  1097. Metabolic reprogramming and redox adaptation in sorafenib‐resistant leukemia cells: detected by untargeted metabolomics and stable isotope tracing analysis
  1098. Adherence Affects Monocyte Innate Immune Function and Metabolic reprogramming after Lipopolysaccharide Stimulation In Vitro
  1099. BAI1 acts as a tumor suppressor in lung cancer A549 cells by inducing Metabolic reprogramming via the SCD1/HMGCR module
  1100. Phytocompounds Targeting Metabolic reprogramming in Cancer: An Assessment of Role, Mechanisms, Pathways, and Therapeutic Relevance
  1101. The Role of Aberrant Metabolism in Cancer: Insights Into the Interplay Between Cell Metabolic reprogramming, Metabolic Syndrome, and Cancer
  1102. A Heterocyst-Specific Antisense RNA Contributes to Metabolic reprogramming in Nostoc sp. PCC 7120
  1103. The proteomic analysis shows enrichment of RNA surveillance pathways in adult SHH and extensive Metabolic reprogramming in Group 3 medulloblastomas
  1104. Bridging the gap–a new role for STAT3 in TLR4‐mediated Metabolic reprogramming
  1105. miR-16-5p/PDK4-mediated Metabolic reprogramming is involved in chemoresistance of cervical cancer
  1106. Stellate cells aid growth-permissive Metabolic reprogramming and promote gemcitabine chemoresistance in pancreatic cancer
  1107. Metabolic reprogramming of Salmonella infected macrophages and its modulation by iron availability and the mTOR pathway
  1108. Mitochondrial arginase-2 is essential for IL-10 Metabolic reprogramming of inflammatory macrophages
  1109. Targeting PPAR ligands as possible approaches for Metabolic reprogramming of T cells in cancer immunotherapy
  1110. SIRTUIN 3, ENDOTHELIAL Metabolic reprogramming AND HEART FAILURE WITH PRESERVED EJECTION FRACTION
  1111. Potential of electron transfer and its application in dictating routes of biochemical processes associated with Metabolic reprogramming
  1112. DIO3, the thyroid hormone inactivating enzyme, promotes tumorigenesis and Metabolic reprogramming in high grade serous ovarian cancer
  1113. EVI1 triggers Metabolic reprogramming associated with leukemogenesis and increases sensitivity to L-asparaginase
  1114. Mechanisms of Metabolic reprogramming in Cancer Cells Supporting Enhanced Growth and Proliferation
  1115. Metabolic reprogramming and immune regulation in viral diseases
  1116. Acidosis-induced Metabolic reprogramming in tumor cells enhances the anti-proliferative activity of the PDK inhibitor dichloroacetate
  1117. PGC1α-Mediated Metabolic reprogramming Drives the Stemness of Pancreatic Precursor Lesions
  1118. Protein arginine methyltransferase 3-induced Metabolic reprogramming is a vulnerable target of pancreatic cancer
  1119. The Role of PKM2 in Metabolic reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
  1120. Innate immune training and Metabolic reprogramming in primary monocytes of broiler and laying hens
  1121. Selenium-dependent Metabolic reprogramming during inflammation and resolution
  1122. … in the tumour microenvironment: Interactions with stromal cells and with non-cell components, and impacts on Metabolic reprogramming, horizontal transfer of …
  1123. The Metabolic reprogramming profiles in the liver fibrosis of mice infected with Schistosoma japonicum
  1124. The biological role of Metabolic reprogramming in pancreatic cancer
  1125. … N‐methyltransferase decreases 5‐fluorouracil sensitivity in human esophageal squamous cell carcinoma through Metabolic reprogramming and promoting the …
  1126. Metabolic reprogramming as a feast for virus replication
  1127. Distinctive cellular and Metabolic reprogramming in porcine lung mononuclear phagocytes infected with type 1 PRRSV strains
  1128. Metabolic reprogramming of T regulatory cells in the hypoxic tumor microenvironment
  1129. N6-methyladenosine-induced ERRγ triggers chemoresistance of cancer cells through upregulation of ABCB1 and Metabolic reprogramming
  1130. Mitochondrial AIF loss causes Metabolic reprogramming, caspase-independent cell death blockade, embryonic lethality, and perinatal hydrocephalus
  1131. Calcium carbonate nanoparticles stimulate tumor Metabolic reprogramming and modulate tumor metastasis
  1132. Escherichia coli foster bladder cancer cell line progression via epithelial mesenchymal transition, stemness and Metabolic reprogramming
  1133. p62-dependent autophagy in airway smooth muscle cells regulates Metabolic reprogramming and promotes airway remodeling
  1134. Metabolic reprogramming involving glycolysis in the hibernating brown bear skeletal muscle
  1135. Phytochemicals Block Glucose Utilization and Lipid Synthesis to Counteract Metabolic reprogramming in Cancer Cells
  1136. Metabolic reprogramming in childhood acute lymphoblastic leukemia
  1137. Pulsed glucocorticoids enhance dystrophic muscle performance through epigenetic-Metabolic reprogramming
  1138. Metabolic reprogramming links chronic intestinal inflammation and the oncogenic transformation in colorectal tumorigenesis
  1139. Sorting Nexin 10 mediates Metabolic reprogramming of macrophages in atherosclerosis through the Lyn-dependent TFEB signaling pathway
  1140. Nrf2 Mediates Metabolic reprogramming in Non-Small Cell Lung Cancer
  1141. Metabolic reprogramming of Fibroblasts as Therapeutic Target in Rheumatoid Arthritis and Cancer: Deciphering Key Mechanisms Using Computational Systems …
  1142. Metabolite and phytohormone profiling illustrates Metabolic reprogramming as an escape strategy of deepwater rice during partially submerged stress
  1143. Overexpression of lncRNA EPB41L4A-AS1 Induces Metabolic reprogramming in Trophoblast Cells and Placenta Tissue of Miscarriage
  1144. Cellular Stress Responses and Metabolic reprogramming in Cancer Progression and Dormancy
  1145. Growing Human Hepatocellular Tumors Undergo a Global Metabolic reprogramming
  1146. Metabolic reprogramming and immunity in cancer
  1147. Low levels of AMPK promote epithelial‐mesenchymal transition in lung cancer primarily through HDAC4‐and HDAC5‐mediated Metabolic reprogramming
  1148. Mutant KRAS drives Metabolic reprogramming and autophagic flux in premalignant pancreatic cells
  1149. Glucose induces Metabolic reprogramming in neutrophils during type 2 diabetes to form constitutive extracellular traps and decreased responsiveness to …
  1150. ANKRD22, a novel tumor microenvironment-induced mitochondrial protein promotes Metabolic reprogramming of colorectal cancer cells
  1151. Epigenetic loss of the endoplasmic reticulum–associated degradation inhibitor SVIP induces cancer cell Metabolic reprogramming
  1152. POU1F1 transcription factor induces Metabolic reprogramming and breast cancer progression via LDHA regulation
  1153. A PAS Protein Directs Metabolic reprogramming during Cryptococcal Adaptation to Hypoxia
  1154. An AMPK-dependent, non-canonical p53 pathway plays a key role in adipocyte Metabolic reprogramming
  1155. Gastric Cancer Stem Cells: A Glimpse on Metabolic reprogramming
  1156. AHR regulates Metabolic reprogramming to promote SIRT1-dependent keratinocyte differentiation
  1157. Metabolic reprogramming is a hallmark of metabolism itself
  1158. TNFAIP8 drives Metabolic reprogramming to promote prostate cancer cell proliferation
  1159. Metabolic reprogramming due to hypoxia in pancreatic cancer: Implications for tumor formation, immunity, and more
  1160. Frontline Science: AMPK regulates Metabolic reprogramming necessary for interferon production in human plasmacytoid dendritic cells
  1161. Systems level profiling of arginine starvation reveals MYC and ERK adaptive Metabolic reprogramming
  1162. Acly promotes Metabolic reprogramming and induction of IRF4 during early CD8+ T cell activation
  1163. STING regulates Metabolic reprogramming in macrophages via HIF-1α during Brucella infection
  1164. Metabolic reprogramming augments potency of human pSTAT3–inhibited iTregs to suppress alloreactivity
  1165. Waterlogging tolerance rendered by oxylipin-mediated Metabolic reprogramming in Arabidopsis
  1166. Aryl hydrocarbon receptor mediates benzo [a] pyrene-induced Metabolic reprogramming in human lung epithelial BEAS-2B cells
  1167. Dropwort-induced Metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
  1168. Metabolic reprogramming and epigenetic modifications on the path to cancer
  1169. Molecular and Metabolic reprogramming: Pulling the Strings Toward Tumor Metastasis
  1170. Pre-operative exercise therapy triggers anti-inflammatory trained immunity of Kupffer cells through Metabolic reprogramming
  1171. IL-10 Enhances Human Natural Killer Cell Effector Functions via Metabolic reprogramming Regulated by mTORC1 Signaling
  1172. MiR-1297 negatively regulates Metabolic reprogramming in glioblastoma via repressing KPNA2
  1173. C/EBPβ-LIP induces cancer-type Metabolic reprogramming by regulating the let-7/LIN28B circuit in mice
  1174. A microbial-based biostimulant enhances sweet pepper performance by Metabolic reprogramming of phytohormone profile and secondary metabolism
  1175. Glucosinolate induces transcriptomic and Metabolic reprogramming in Helicoverpa armigera
  1176. Involvement of collagen XVII in pluripotency gene expression and Metabolic reprogramming of lung cancer stem cells
  1177. Metabolic reprogramming associated with progression of renal ischemia reperfusion injury assessed with hyperpolarized [1-13 C] pyruvate
  1178. A Metabolic reprogramming of Glycolysis and Glutamine Metabolism Is a Requisite for Renal Fibrogenesis—Why and How?
  1179. Glucose Metabolic reprogramming and cell proliferation arrest in colorectal micropapillary carcinoma
  1180. What Antarctic Plants Can Tell Us about Climate Changes: Temperature as a Driver for Metabolic reprogramming
  1181. Neuroimmune metabolism: Uncovering the role of Metabolic reprogramming in central nervous system disease
  1182. Metabolic reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy
  1183. Differential Metabolic reprogramming in Paenibacillus Alvei-primed Sorghum bicolor seedlings in response to Fusarium pseudograminearum infection
  1184. Mitochondrial MUL1 E3 ubiquitin ligase regulates Hypoxia Inducible Factor (HIF-1α) and Metabolic reprogramming by modulating the UBXN7 cofactor protein
  1185. Molecular processes mediating hyperhomocysteinemia-induced Metabolic reprogramming, redox regulation and growth inhibition in endothelial cells
  1186. Cell fate, Metabolic reprogramming and lncRNA of tumor-initiating stem-like cells induced by alcohol
  1187. Metabolic reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy
  1188. Regulation of Metabolic reprogramming by Long Non-Coding RNAs in Cancer
  1189. Mitochondria and Its Permeability Transition Pore in Cancer Metabolic reprogramming
  1190. Regulation of the Mitochondrion-Fatty Acid Axis for the Metabolic reprogramming of Chlamydia trachomatis during Treatment with β-Lactam Antimicrobials
  1191. Long non‑coding RNAs: Key regulators involved in Metabolic reprogramming in cancer
  1192. Metabolic reprogramming in chondrocytes to promote mitochondrial respiration reduces downstream features of osteoarthritis
  1193. The Macrophage Response Is Driven by Mesenchymal Stem Cell-Mediated Metabolic reprogramming
  1194. Metabolic reprogramming and angiogenesis in primary cutaneous Merkel cell carcinoma: expression of hypoxia‐inducible factor‐1α and its central downstream …
  1195. Metabolic reprogramming of myeloid‐derived suppressor cells: An innovative approach confronting challenges
  1196. TRPV1 sustains microglial Metabolic reprogramming in Alzheimer’s disease
  1197. Multiomic profiling of tyrosine kinase inhibitor-resistant K562 cells suggests Metabolic reprogramming to promote cell survival
  1198. HBXIP drives Metabolic reprogramming in hepatocellular carcinoma cells via METTL3‐mediated m6A modification of HIF‐1α
  1199. Metabolic reprogramming of hydrogenosomal amino acids in Trichomonas vaginalis under glucose restriction
  1200. LncRNA-SLC16A1-AS1 induces Metabolic reprogramming during Bladder Cancer progression as target and co-activator of E2F1
  1201. Pan-Cancer Analysis Reveals Distinct Metabolic reprogramming in Different Epithelial–Mesenchymal Transition Activity States
  1202. DDR1 Affects Metabolic reprogramming in Breast Cancer Cells by Cross-Talking to the Insulin/IGF System
  1203. Beyond Il-5: Metabolic reprogramming and Stromal Support Are Prerequisite for Generation and Survival of Long-Lived Eosinophil
  1204. Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
  1205. Cholesterol Metabolic reprogramming in cancer and its pharmacological modulation as therapeutic strategy
  1206. Constraints-based analysis identifies NAD+ recycling through Metabolic reprogramming in antibiotic resistant Chromobacterium violaceum
  1207. Erythrocyte adenosine A2B receptor prevents cognitive and auditory dysfunction by promoting hypoxic and Metabolic reprogramming
  1208. PAX2 promotes epithelial ovarian cancer progression involving fatty acid Metabolic reprogramming
  1209. Glial Metabolic reprogramming in Amyotrophic Lateral Sclerosis
  1210. Dichloroacetate-induced Metabolic reprogramming improves lifespan in a Drosophila model of surviving sepsis
  1211. Comprehensive Analysis of the Relationship Between Metabolic reprogramming and Immune Function in Prostate Cancer
  1212. Metabolic reprogramming of macrophages in atherosclerosis: Is it all about cholesterol?
  1213. Comprehensive metabolomics insights into benzo [a] pyrene-induced Metabolic reprogramming related to H460 cell invasion and migration
  1214. Cancer Stem Cell-Associated Pathways in the Metabolic reprogramming of Breast Cancer
  1215. … proteomics decodes clusterin as a critical regulator of paternal factors responsible for impaired compensatory Metabolic reprogramming in recurrent pregnancy loss
  1216. Crosstalk of the IκB Kinase with Spliced X-Box Binding Protein 1 Couples Inflammation with Glucose Metabolic reprogramming in Epithelial–Mesenchymal Transition
  1217. Mitochondrial dynamics links PINCH-1 signaling to proline Metabolic reprogramming and tumor growth
  1218. VDAC1 Silencing in Cancer Cells Leads to Metabolic reprogramming That Modulates Tumor Microenvironment
  1219. Disrupted macrophage Metabolic reprogramming in aged soleus muscle during early recovery following disuse atrophy
  1220. Multi-omics analyses detail Metabolic reprogramming in lipids, carnitines, and use of glycolytic intermediates between prostate small cell neuroendocrine carcinoma …
  1221. Peroxynitrite supports a Metabolic reprogramming in merlin-deficient Schwann cells and promotes cell survival
  1222. Hedgehog interacting protein (HHIP) represses airway remodeling and Metabolic reprogramming in COPD-derived airway smooth muscle cells
  1223. Tumor Metabolome: Therapeutic Opportunities Targeting Cancer Metabolic reprogramming
  1224. A requirement for autophagy in HMGA2-induced Metabolic reprogramming to support Cd-induced migration
  1225. An “EZ” Epigenetic Road to Leukemia Stem Cell Metabolic reprogramming?
  1226. Mortalin/glucose-regulated protein 75 promotes the cisplatin-resistance of gastric cancer via regulating anti-oxidation/apoptosis and Metabolic reprogramming
  1227. Targeting Metabolic reprogramming to Improve Breast Cancer Treatment: An In Vitro Evaluation of Selected Metabolic Inhibitors Using a Metabolomic Approach
  1228. oxLDL-Induced Trained Immunity Is Dependent on Mitochondrial Metabolic reprogramming
  1229. Transcriptomic and Metabolic Network Analysis of Metabolic reprogramming and IGF-1 Modulation in SCA3 Transgenic Mice
  1230. Transcriptomic and metabolomic characterization of post-hatch Metabolic reprogramming during hepatic development in the chicken
  1231. Parallel Murine and Human Aortic Wall Genomics Reveals Metabolic reprogramming as Key Driver of Abdominal Aortic Aneurysm Progression
  1232. A powerful tool to study Metabolic reprogramming in pediatric cancers
  1233. Integration of metabolomics and existing omics data reveals new insights into phytoplasma-induced Metabolic reprogramming in host plants
  1234. Primary Aldosteronism: Metabolic reprogramming and the Pathogenesis of Aldosterone-Producing Adenomas
  1235. The Impact of Olive Oil Compounds on the Metabolic reprogramming of Cutaneous Melanoma Cell Models
  1236. Metabolic reprogramming: Strategy for Ischemic Stroke Treatment by Ischemic Preconditioning
  1237. The value of a Metabolic reprogramming-related gene signature for pancreatic adenocarcinoma prognosis prediction
  1238. Metabolic reprogramming of inner ear cell line HEI-OC1 after dexamethasone application
  1239. Host Metabolic reprogramming in response to SARS-CoV-2 infection: A systems biology approach
  1240. Yeast prion-based Metabolic reprogramming induced by bacteria in fermented foods
  1241. The Metabolic reprogramming of Frem2 Mutant Mice Embryos in Cryptophthalmos Development
  1242. Multiomics integrative analysis reveals antagonistic roles of CBX2 and CBX7 in Metabolic reprogramming of breast cancer
  1243. Matrix Metalloproteinase-11 Promotes Early Mouse Mammary Gland Tumor Growth through Metabolic reprogramming and Increased IGF1/AKT/FoxO1 Signaling …
  1244. Regulation of humoral immune response by HIF-1α-dependent Metabolic reprogramming of the germinal center reaction
  1245. Metabolic reprogramming in Congenital Cyanotic Heart Disease: Another Fight in Puberty?
  1246. Emerging roles of non-coding RNAs in the Metabolic reprogramming of tumor-associated macrophages
  1247. Metabolic reprogramming orchestrates CD4+ T-cell immunological status and restores cardiac dysfunction in autoimmune induced-dilated cardiomyopathy …
  1248. Cerebellar and multi-system Metabolic reprogramming associated with trauma exposure and post-traumatic stress disorder (PTSD)-like behavior in mice
  1249. P53/PANK1/miR‐107 signalling pathway spans the gap between Metabolic reprogramming and insulin resistance induced by high‐fat diet
  1250. Global phosphoproteomic analysis reveals significant Metabolic reprogramming in the termination of liver regeneration in mice
  1251. Upregulated ethanolamine phospholipid synthesis via selenoprotein I is required for effective Metabolic reprogramming during T cell activation
  1252. Cholesterol-Induced Metabolic reprogramming in Breast Cancer Cells Is Mediated via the ERRα Pathway
  1253. Metabolic reprogramming in macrophage responses
  1254. Comprehensive Metabolomic Analysis Reveals Dynamic Metabolic reprogramming in Hep3B Cells with Aflatoxin B1 Exposure
  1255. MTAP deficiency-induced Metabolic reprogramming creates a vulnerability to co-targeting de novo purine synthesis and glycolysis in pancreatic cancer
  1256. The Metabolic reprogramming and vulnerability of SF3B1 mutations
  1257. Metabolic reprogramming related to whole-chromosome instability in models for Hürthle cell carcinoma
  1258. Dexfenfluramine and pergolide cause heart valve disease via valve Metabolic reprogramming and ongoing matrix remodeling
  1259. Multi-scale comparative transcriptome analysis reveals key genes and Metabolic reprogramming processes associated with oil palm fruit abscission
  1260. Exploring Metabolic reprogramming in melanoma via acquired resistance to the oxidative phosphorylation inhibitor phenformin
  1261. Fructose drives mitochondrial Metabolic reprogramming in podocytes via Hmgcs2-stimulated fatty acid degradation
  1262. CHAF1A Blocks Neuronal Differentiation and Promotes Neuroblastoma Oncogenesis via Metabolic reprogramming
  1263. Metabolic reprogramming rejuvenates aged myeloid cells restoring cognition
  1264. ARRB1 Regulates Metabolic reprogramming to Promote Glycolysis in Stem Cell-Like Bladder Cancer Cells
  1265. … of the Fourth-Stage Larval Angiostrongylus cantonensis Promotes Alternative Activation of Macrophages Through Metabolic reprogramming by the PI3K-Akt …
  1266. Implication of BAG5 downregulation in Metabolic reprogramming of cisplatin-resistant ovarian cancer cells via mTORC2 signaling pathway
  1267. IL‐22‐mediated renal Metabolic reprogramming via PFKFB3 to treat kidney injury
  1268. Metabolic reprogramming by Reduced Calorie Intake or Pharmacological Caloric Restriction Mimetics for Improved Cancer Immunotherapy
  1269. … Dysfunction in Neurodegenerative Diseases—New Mechanistic Insights and the Potential of Hypoxia as a Prospective Therapy Targeting Metabolic reprogramming
  1270. NAD+ Inhibits the Metabolic reprogramming of RPE Cells in Early Age-related Macular Degeneration by Upregulating Mitophagy
  1271. Honokiol Restores Microglial Phagocytosis by Reversing Metabolic reprogramming
  1272. Metabolic reprogramming in polycystic kidney disease explained by super-enhancers and CDK7: new therapeutic targets?
  1273. Metabolic reprogramming of GMP Grade Cord Tissue Derived Mesenchymal Stem Cells Enhances Their Suppressive Potential in GVHD
  1274. Qian Yang Yu Yin Granule Improves Renal Injury of Hypertension by Regulating Metabolic reprogramming Mediated by HIF-1α/PKM2 Positive Feedback …
  1275. Metabolic reprogramming as an emerging mechanism of resistance to endocrine therapies in prostate cancer
  1276. … Metabolic profile and 18 F-FDG-Positron Emission Tomography-Computed Tomography parameters reveal the complexity of the Metabolic reprogramming …
  1277. Thiomyristoyl ameliorates colitis by blocking the differentiation of Th17 cells and inhibiting SIRT2-induced Metabolic reprogramming
  1278. Tofacitinib therapy intercepts macrophage Metabolic reprogramming instigated by SARS‐CoV‐2 Spike protein
  1279. FLCN alteration drives Metabolic reprogramming towards nucleotide synthesis and cyst formation in salivary gland
  1280. HMG-CoA synthase 2 drives brain Metabolic reprogramming in cocaine exposure
  1281. … is a specific factor in the neoplastic microenvironment of HCC that causes MDR via GRP75 regulation of the redox balance and Metabolic reprogramming
  1282. DRP1 Promotes BRAFV600E-Driven Tumor Progression and Metabolic reprogramming in Colorectal Cancer
  1283. GCH1 induces immunosuppression through Metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
  1284. 4′‐Bromo‐resveratrol, a dual Sirtuin‐1 and Sirtuin‐3 inhibitor, inhibits melanoma cell growth through mitochondrial Metabolic reprogramming
  1285. Microglial MT1 activation inhibits LPS‐induced neuroinflammation via regulation of Metabolic reprogramming
  1286. … landscape reveals the transcriptional regulatory circuits controlling key-signaling pathways and Metabolic reprogramming during tumor evolution
  1287. Mechanisms and pathways of Metabolic reprogramming of colorectal cancer
  1288. Metabolic reprogramming in cancer: the bridge that connects intracellular stresses and cancer behaviors
  1289. … of pyruvate dehydrogenase kinase‑1 by dicoumarol enhances the sensitivity of hepatocellular carcinoma cells to oxaliplatin via Metabolic reprogramming
  1290. The role of Metabolic reprogramming and de novo amino acid synthesis in collagen protein production by myofibroblasts: implications for organ fibrosis and cancer
  1291. Therapeutic potential of α, β‐thujone through Metabolic reprogramming and caspase‐dependent apoptosis in ovarian cancer cells
  1292. Metabolic reprogramming and signaling to chromatin modifications in tumorigenesis
  1293. Anxiolytic drug FGIN-1-27 ameliorates autoimmunity by Metabolic reprogramming of pathogenic Th17 cells
  1294. Genome-scale Metabolic modeling reveals SARS-CoV-2-induced host Metabolic reprogramming and identifies Metabolic antiviral targets
  1295. NOX4-Derived ROS Mediates TGF-β1-Induced Metabolic reprogramming during Epithelial-Mesenchymal Transition through the PI3K/AKT/HIF-1α Pathway in …
  1296. Role of psoriatic keratinocytes in the Metabolic reprogramming of dermal mesenchymal stem cells
  1297. Mitochondrial complex I inhibitor deguelin induces Metabolic reprogramming and sensitizes vemurafenib‐resistant BRAFV600E mutation bearing metastatic …
  1298. Aldolase triggers Metabolic reprogramming in colorectal cancer in hypoxia and stiff desmoplastic microenvironments
  1299. Lactate promotes cardiomyocyte dedifferentiation through Metabolic reprogramming
  1300. Pyruvate dehydrogenase kinase 4‐mediated Metabolic reprogramming is involved in rituximab resistance in diffuse large B‐cell lymphoma by affecting the …
  1301. SIRT3 affects mitochondrial Metabolic reprogramming via the AMPK–PGC‐1α axis in the development of benign prostatic hyperplasia
  1302. Atypical immunometabolism and Metabolic reprogramming in liver cancer: Deciphering the role of gut microbiome.
  1303. Targeting Amino Acid Metabolic reprogramming via L-Type Amino Acid Transporter 1 (LAT1) for Endocrine-Resistant Breast Cancer
  1304. Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and Metabolic reprogramming in lung adenocarcinoma based on …
  1305. Nano-realgar suppresses lung cancer stem cell growth by repressing Metabolic reprogramming
  1306. NIX-mediated mitophagy regulate Metabolic reprogramming in phagocytic cells during mycobacterial infection
  1307. Mineral-enriched deep-sea water modulates lactate metabolism via PGC-1α-mediated Metabolic reprogramming
  1308. SQLE Mediates Metabolic reprogramming to Promote LN Metastasis in Castration-Resistant Prostate Cancer
  1309. Mitochondrial DNA mutations contribute to high altitude pulmonary edema via increased oxidative stress and Metabolic reprogramming during hypobaric hypoxia
  1310. PRRX1‐induced epithelial‐to‐mesenchymal transition in salivary adenoid cystic carcinoma activates the Metabolic reprogramming of free fatty acids to promote …
  1311. Metabolic reprogramming in Health and Disease
  1312. Fursultiamine Alleviates Choroidal Neovascularization by Suppressing Inflammation and Metabolic reprogramming
  1313. reprogramming of cellular Metabolic pathways by human oncogenic viruses
  1314. Metabolic reprogramming and inflammatory response induced by D-lactate in bovine fibroblast-like synoviocytes depends on HIF-1 activity
  1315. Metabolic reprogramming and elevation of glutathione in chromophobe renal cell carcinomas
  1316. Metabolic reprogramming Drives Pituitary Tumor Growth through Epigenetic Regulation of TERT
  1317. NKp46+ lamina propria natural killer cells undergo Metabolic reprogramming in a mouse experimental colitis model
  1318. Bio-inspired nanoenzyme for Metabolic reprogramming and anti-inflammatory treatment of hyperuricemia and gout
  1319. Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via Metabolic reprogramming
  1320. Molecular Mechanisms Controlling the Metabolic reprogramming of Immune Cells Under Pathophysiological Conditions
  1321. Metabolic reprogramming of Mouse Bone Marrow Derived Macrophages Following Erythrophagocytosis
  1322. Metabolic reprogramming of macrophages and its involvement in inflammatory diseases
  1323. Computational data mining method for isotopomer analysis in the quantitative assessment of Metabolic reprogramming
  1324. Age-induced Metabolic reprogramming underlies cancer progression
  1325. SIRT7–SREBP1 restrains cancer cell Metabolic reprogramming by upregulating IDH1
  1326. Monocytes exposed to plasma from patients with Alzheimer’s disease undergo Metabolic reprogramming
  1327. Cutting edge: Metabolic immune reprogramming, reactive oxygen species, and cancer
  1328. Metabolic reprogramming and tumor immunity under hypoxic microenvironment
  1329. Metabolic reprogramming by the Excessive AMPK Activation Exacerbates Antigen-Specific Memory CD8+ T Cell Differentiation after Acute Lymphocytic …
  1330. Metformin and 2-Deoxyglucose Collaboratively Suppress Human CD4+ T Cell Effector Functions and Activation-Induced Metabolic reprogramming
  1331. Nanoparticle-Mediated Lipid Metabolic reprogramming of T Cells in Tumor Microenvironments for ImmunoMetabolic Therapy
  1332. A proteomic analysis of GSD-1a in mouse livers: evidence for Metabolic reprogramming, inflammation, and macrophage polarization
  1333. 515 Metabolic reprogramming of antitumor CD8+ T cell immunity
  1334. PINCH-1 promotes Δ1-pyrroline-5-carboxylate synthase expression and contributes to proline Metabolic reprogramming in lung adenocarcinoma
  1335. Author Correction: Metabolic reprogramming by the S-nitroso-CoA reductase system protects against kidney injury
  1336. Downregulation of GLUT3 impairs STYK1/NOK‑mediated Metabolic reprogramming and proliferation in NIH‑3T3 cells
  1337. Spatial-resolved metabolomics reveals tissue-specific Metabolic reprogramming in diabetic nephropathy by using mass spectrometry imaging
  1338. Metabolic reprogramming of the cystic fibrosis neutrophil drives Interleukin-1β via the NLRP3 inflammasome
  1339. Platelets Promote Pro-Angiogenic Activity of Mesenchymal Stem Cells via Mitochondrial Transfer and Metabolic reprogramming
  1340. TSC-Insensitive Rheb Mutations Induce Oncogenic Transformation Through a Combination of Hyperactive mTORC1 Signalling and Metabolic reprogramming
  1341. Metabolic reprogramming and its role in plant cold acclimation
  1342. Fanning the Flames of Inflammaging: Impact of Monocyte Metabolic reprogramming
  1343. Metabolic reprogramming of Myeloid Cells Upon TLR4 Stimulation
  1344. Pharmacologic Inhibition of B Cell-Receptor-Associated Kinases with CG-806 Induces Apoptosis and Metabolic reprogramming in Aggressive Non-Hodgkin …
  1345. Metabolic reprogramming and the Control of Anoikis Resistance in Cancer
  1346. Host Metabolic reprogramming of Pseudomonas aeruginosa by phage-based quorum sensing modulation
  1347. FADS2-mediated fatty acid desaturation and cholesterol esterification are signatures of Metabolic reprogramming during melanoma progression
  1348. … MECHANISMS: TERT EXPRESSION AND THE ALT PATHWAY INDUCE UNIQUE MRS-DETECTABLE Metabolic reprogramming IN LOW-GRADE GLIOMAS
  1349. Tissue-specific Metabolic reprogramming during wound induced de novo organ formation in tomato hypocotyl explants
  1350. Metabolic reprogramming, Meaning and Implications
  1351. Fatty acid Metabolic reprogramming promotes C. elegans development
  1352. Muscle Metabolic reprogramming underlies the resistance of liver fatty acid–binding protein (LFABP)-null mice to high-fat feeding–induced decline in exercise …
  1353. Dissecting the Metabolic reprogramming of Maize Root under Nitrogen Limiting Stress Condition
  1354. Hyperglycemia-Induced Metabolic reprogramming Mediates a Proatherogenic Phenotype in Healthy Human Monocytes
  1355. Correction: miR-27a is a master regulator of Metabolic reprogramming and chemoresistance in colorectal cancer
  1356. Histone Butyrylation/Acetylation Remains Unchanged in Triple Negative Breast Cancer Cells after a Long Term Metabolic reprogramming
  1357. A drug potency signature links progression of chronic lymphocytic leukemia to mitochondria-related stress responses and Metabolic reprogramming under hypoxia
  1358. Functional Characterization of the Lin28/let-7 Circuit During Forelimb Regeneration in Ambystoma mexicanum and Its Influence on Metabolic reprogramming
  1359. Urolithin A, a Gut Metabolite, Induces Metabolic reprogramming of Adipose Tissue by Promoting M2 Macrophage Polarization and Mitochondrial Function (OR12-02 …
  1360. Tumor-Derived Exosomes Drive Immunosuppressive Macrophages in a Pre-Metastatic Niche Through NF-Kb Dependent Glycolytic Metabolic reprogramming
  1361. Commentary on ‘Metabolic reprogramming‐associated genes predict overall survival for rectal cancer’
  1362. Advances in the role of m 6 A RNA modification in cancer Metabolic reprogramming
  1363. Abstract C59: NRF2 drives Metabolic reprogramming in irradiated pancreatic cancer cells and promotes radioresistance
  1364. Small Molecule from Natural Phytochemical Mimics Dietary Restriction by Modulating FoxO3a and Metabolic reprogramming
  1365. Metabolic reprogramming, Questioning, and Implications for Cancer. Biology 2021, 10, 129
  1366. Glucose Metabolic reprogramming in Cancer Microenvironment
  1367. Deletion of CISH in Human Pluripotent Stem Cell-Derived Natural Killer Cells Enhances Anti-Tumor Activity Via Metabolic reprogramming
  1368. Metabolic reprogramming and Molecular Rewiring in Cancer: Therapeutic Opportunities
  1369. Melatonin could Alleviate the Dysregulation of Metabolic reprogramming in Periodontitis—Implications in Host Modulatory Therapy
  1370. Metabolic reprogramming by c-MET Inhibition as a Targetable Vulnerability in Glioblastoma
  1371. … . Although studies have shown Metabolic reprogramming to be linked to ESCC development, no prognostic Metabolic biomarkers or potential therapeutic Metabolic …
  1372. Role of Bladder Cancer Metabolic reprogramming in the Effectiveness of Immunotherapy. Cancers 2021, 13, 288
  1373. Metabolic reprogramming of Cancer Cells during Tumor Progression and Metastasis. Metabolites 2021, 11, 28
  1374. The IRG1-itaconate axis promotes viral replication via Metabolic reprogramming and protein prenylation
  1375. Gastric Cancer Stem Cells: A Glimpse on Metabolic reprogramming. Front
  1376. Metabolic reprogramming of cytotoxic T lymphocytes by high glucose enhances pancreatic beta cell apoptosis via TRAIL
  1377. The cancer Metabolic reprogramming and immune response
  1378. Developmental changes and Metabolic reprogramming during establishment of infection and progression of Trypanosoma brucei brucei through its insect host
  1379. Commentary: SGLT2 inhibitors reduce mortality and heart failure in patients with type 2 diabetes mellitus—is Metabolic reprogramming the mechanism for these …
  1380. Antioxidant-Conjugated Peptide Attenuated Metabolic reprogramming in Pulmonary Hypertension
  1381. Metabolic reprogramming from Glycolysis to Fatty Acid Uptake and beta-Oxidation in Platinum-Resistant Cancer Cells
  1382. OMRT-13. Delivery of Ubidecarenone (BPM 31510) to mitochondria effectuates Metabolic reprogramming and redox activated apoptosis in Glioblastoma
  1383. Investigating Metabolic reprogramming in Adipocytes via 13C-Based Techniques
  1384. Lipid Metabolic reprogramming and Metabolic Stress in Liver Cancer
  1385. OP0312 Metabolic reprogramming IN MEMORY CD4+ T CELLS IS ASSOCIATED WITH REACTIVE OXYGEN INDUCED IMMUNE CELL DYSFUNCTION …
  1386. NRF2-dependent Metabolic reprogramming is required for tumor recurrence following oncogene inhibition
  1387. Metabolic and functional reprogramming of myeloid-derived suppressor cells and their therapeutic control in glioblastoma
  1388. Targeting Metabolic reprogramming of Colorectal Cancer
  1389. Metabolic reprogramming and mitochondrial dysfunction in HepG2 cells as potential drivers of AIP pathophysiology
  1390. Metformin in Cervical Cancer: Metabolic reprogramming
  1391. Identification of Metabolic reprogramming Related Gene Signature to Predict the Prognosis of Bladder Cancer Patients
  1392. Yin and Yang of YY1 regulation on tumor Metabolic reprogramming
  1393. CBX2 and CBX7 antagonistically regulate Metabolic reprogramming in breast cancer
  1394. Publisher correction: Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment
  1395. Metabolic reprogramming, Questioning, and Implications for Cancer
  1396. Defining Roles of Metabolic reprogramming in Pancreatic Tumorigenesis and Tumor Maintenance
  1397. Myotube hypertrophy is associated with cancer-like Metabolic reprogramming and limited by PHGDH
  1398. Metabolic reprogramming by In Utero Maternal Benzene Exposure
  1399. Metabolic reprogramming to optimise breast cancer treatment
  1400. Metabolic reprogramming and host-immune response against Crimean-Congo Hemorrhagic Fever Viruses
  1401. Metabolic reprogramming of Fibro/Adipogenic Progenitors Facilitates Muscle Regeneration
  1402. Stellate Cells Aid Growth-Permissive Metabolic reprogramming and Promote Gemcitabine Chemoresistance in Pancreatic Cancer. Cancers 2021, 13, 601
  1403. … Genome Regulator TFAM Modulates Head and Neck Tumorigenesis Through Activation of Intracellular Metabolic reprogramming and Oncogenic Effectors
  1404. Interleukin-22 mediated renal Metabolic reprogramming via PFKFB3 to treat kidney injury
  1405. TRPM7 Silencing Modulates Glucose Metabolic reprogramming to Inhibit the Growth of Ovarian Cancer by Enhancing AMPK Activation to Promote HIF-1α …
  1406. Metabolic reprogramming Promotes Myogenesis During Aging
  1407. Circrhbdd1 Augments M6a-Dependent Metabolic reprogramming and Restricts Anti-PD-1 Therapy in Hepatocellular Carcinoma
  1408. IFNγ Mediated Monocyte Metabolic reprogramming
  1409. Longitudinal blood cell transcriptomic profiling and in vitro temporal proteomics provides novel insights into Metabolic reprogramming and host-immune …
  1410. Schistosoma mansoni infection induces long-lived sex-specific Metabolic reprogramming of the myeloid lineage
  1411. Mitochondrial CaMKII causes Metabolic reprogramming, energetic insufficiency, and dilated cardiomyopathy
  1412. Metabolic reprogramming in Triple-Negative Breast Cancer: Covid 19
  1413. ATPIF1 inactivation promotes antitumor immunity through Metabolic reprogramming of CD8+ T cells
  1414. Metabolic reprogramming of Cystic Fibrosis Macrophages through the Unfolded Protein Response
  1415. S-Glutathionylation of Pyruvate Kinase M2 Is Associated with Metabolic reprogramming and Cytokine Production in the Development of Allergic Obese Airway …
  1416. RNA Seq Analysis Reveal Differential Expression of Genes Associated With Metabolic reprogramming, Defense and Signaling in Two Contrasting Indigenous …
  1417. Unique Metabolic reprogramming in Pseudomonas Aeruginosa P4 Facilitates the Unusual Concurrence of P-solubilizing and Biocontrol Traits Under P …
  1418. Targeting Metabolic reprogramming to Radiosensitize Glioblastoma Stem Cells
  1419. The Human Cytomegalovirus UL38 protein drives mTOR-independent Metabolic flux reprogramming by inhibiting TSC2
  1420. NK cell-mediated immunotherapy: The exquisite role of PGC-1a in Metabolic reprogramming
  1421. SUN-643 Potential Contributions of Gut Microbiota-Liver Axis to the Transgenerational Metabolic reprogramming of Maternal Exercise
  1422. Starvation Induced Autophagy Promotes The Progression of Bladder Cancer By LDHA Mediated Metabolic reprogramming
  1423. The retinoblastoma protein mediates Metabolic reprogramming in lung cancer.
  1424. BCR-Induced Ca 2+ Signals Dynamically Tune Key Checkpoints that Control the Survival, Metabolic reprogramming, and Proliferation of Naïve B Cells
  1425. PDK4-Mediated Metabolic reprogramming Promotes Rituximab Resistance in Diffuse Large B-Cell Lymphoma Via Negative Regulation of MS4A1/CD20
  1426. β-Elemene Inhibits Proliferation of Non-Small-Cell Lung Cancer by Targeting ALDH3A1 to Regulate Metabolic reprogramming
  1427. Cellular Metabolic reprogramming controls sugar appetite
  1428. O-GlcNAcylation of SAMHD1 Indicating a Link between Metabolic reprogramming and Anti-HBV Immunity
  1429. Role of Metabolic reprogramming in drug resistance to epidermal growth factor tyrosine kinase inhibitors in non-small cell lung cancer.
  1430. Metabolic reprogramming in Pancreatic Cancer: Balancing Lipid Droplet Storage and Catabolism During Tumor Cell Invasion
  1431. Targeting Lipoprotein (A)-Induced Endothelial Cell Metabolic reprogramming Reverses Inflammation And Leukocyte Migration
  1432. Carbon-ion Evokes Metabolic reprogramming and Individualized Response in Prostate Cancer
  1433. Molecular Mechanisms of Metabolic reprogramming in Pancreatic Cancer
  1434. Conserved Virulence-Linked Metabolic reprogramming in Clostridioides Difficile Identified Through Genome-Scale Metabolic Network Analysis
  1435. Genetic regulation of nitric oxide-mediated Metabolic reprogramming in dendritic cells
  1436. Stroma secreted IL6 selects for “stem-like” population and alters pancreatic tumor microenvironment by reprogramming Metabolic pathways
  1437. Deficiency of Tumor Suppressor Merlin Induces Metabolic reprogramming in Breast Cancer
  1438. Erratum: Metabolic reprogramming of Pancreatic Cancer Mediated by CDK4/6 Inhibition Elicits Unique Vulnerabilities (Cell Reports (2016) 14 (5)(979–990) …
  1439. Circadian light-mediated endothelial Metabolic reprogramming
  1440. Hsp22 is the key sensor and balancer in mitochondrial dynamic associated Metabolic reprogramming
  1441. Metabolic Flux Analysis Reveals Hypoxia-Mediated Metabolic reprogramming in Pulmonary Microvascular Endothelial Cells
  1442. Metabolic reprogramming By DNA Tumour Viruses
  1443. JX06, a Novel PDK1 Inhibitor, Induces Myeloma Cell Apoptosis By Metabolic reprogramming and Works Synergistically with Bortezomib
  1444. Characterization of Lipid Metabolic reprogramming and Loss of FOXO3 in Inflammation-Promoted Colon Cancer
  1445. Molecular hydrogen induces Metabolic reprogramming to promote differentiation of glioma stem cells
  1446. Metabolic reprogramming by SLC1A5 downregulation in pancreatic cancer cells
  1447. Human pSTAT3-Inhibited Itregs Prevent Gvhd, Maintain Anti-Leukemia Immunity, and Increase Their Potency after Metabolic reprogramming
  1448. Metabolic reprogramming is Essential for Cell Cycle Progression in Cardiomyocytes
  1449. Studies on Function of Human Mitochondrial Proteases LONP1 and ClpP in Metabolic reprogramming of Cancer
  1450. Metabolic reprogramming from glycolysis to amino acid utilization in cardiac HIF1α deficient mice
  1451. An Insight Into Human Cytomegalovirus Mediated Metabolic reprogramming
  1452. The role of insulin resistance in Metabolic reprogramming and lineage commitment
  1453. THYROID HORMONE AND Metabolic reprogramming IN HEPATOCELLULAR CARCINOMA
  1454. Multifaceted Roles of Hyaluronan in Cancer Stem Cell Regulation: From Microenvironment Formation to Metabolic reprogramming
  1455. The GLS1 inhibitor IPN60090 enhances antitumor immune response through Metabolic reprogramming of T cells and impacts on the tumor microenvironment
  1456. Metabolic reprogramming fuels prostate cancer cells towards enzalutamide resistance
  1457. Investigating Metabolic reprogramming in neurodegenerative disease
  1458. Phytochemicals targeting Metabolic reprogramming in cancer: an assessment of role, mechanisms, pathways and therapeutic relevance
  1459. Definition and validation of targets associated with the Metabolic reprogramming of haematological malignancies
  1460. PHIP Promotes Breast Tumor Initiation by Facilitating Histone Modifications of the Genes that Drive Metabolic reprogramming
  1461. Metabolic reprogramming: Short-term Western Diet Exposure Induces Sustained Changes in Plasma Metabolites
  1462. Metabolic reprogramming of T cells to optimize adoptive T cell therapy
  1463. Tgfβ-Imprinting Decrease CD38 Expression and Lead to Metabolic reprogramming on Primary NK Cell
  1464. Research progress on Metabolic reprogramming of innate immune cells involved in immune-regulation of sepsis
  1465. TNFAIP8 facilitates Metabolic reprogramming in prostate cancer cells
  1466. Cellular IAP (cIAP) Family Proteins Regulate TGF-β1 Induced Metabolic reprogramming of Lung Fibroblasts
  1467. The supramolecular organization of cancer metabolism: From macromolecular crowding to Metabolic reprogramming underlying cancer metastasis and drug …
  1468. Mutant isocitrate dehydrogenase driven Metabolic reprogramming results in therapeutic vulnerability to lactate dehydrogenase inhibition
  1469. Loss of PTEN expression causes Metabolic reprogramming in hepatocellular carcinoma
  1470. Investigating Metabolic reprogramming by GR and LXR in triple negative breast cancer
  1471. Combined Proteomics and Metabolomics Study Reveals the TNF-α Regulated Metabolic reprogramming of Estrogen Receptor/Progesterone Receptor Positive and …
  1472. Integrin β4-mediated Metabolic reprogramming of cancer-associated fibroblasts in triple negative breast cancer
  1473. Solute carrier (SLC) transporter-mediated Metabolic reprogramming during enzalutamide resistance in prostate cancer
  1474. Metabolic reprogramming and Interactions Underlying Bacillus Subtilis Endospore Transition to and Emergence from Dormancy
  1475. HUMAN PANCREATIC CANCER CELLS UNDERGO PROFOUND Metabolic reprogramming TOWARDS CELLULAR STEMNESS AS ADAPTATION TO …
  1476. Study on the Metabolic reprogramming of Lung Cancer Cells Regulated by Docetaxel Based on Metabolomics
  1477. Abstract PS19-01: A sense-antisense RNA interaction drives Metabolic reprogramming in metastatic breast cancer
  1478. Epithelial-Mesenchymal Transition and Metabolic Switching in Cancer: Lessons From Somatic Cell reprogramming
  1479. xCT overexpression induces Metabolic reprogramming, epigenetic alterations, and DNA damage in precancerous airway epithelial cells
  1480. Metabolic reprogramming of human pro-inflammatory B cells in aging and obesity
  1481. In SILICO Simulations Predict a Causative Link Between Increased Glycolysis and Metabolic reprogramming in Autosomal Dominant Polycystic Kidney Disease
  1482. Metabolic reprogramming by c-MET Inhibition as a Targetable Vulnerability in Glioblastoma.
  1483. Effects of Metabolic reprogramming Interventions on Triple-Negative Breast Cancer Cells
  1484. New strategies for the treatment of clear cell renal cell carcinoma: target the Metabolic reprogramming
  1485. P731 High-density lipoproteins rescue diabetes-impaired angiogenesis by restoring cellular Metabolic reprogramming responses to hypoxia
  1486. Improved cloning efficiency by chemically induced Metabolic reprogramming of donor cells used for porcine somatic cell nuclear transfer
  1487. PS976 Metabolic reprogramming OF ACUTE MYELOID LEUKEMIA STEM-PROGENITOR CELLS AT RELAPSE
  1488. The Effects of Resveratrol and Its Analogues on the Sirt5-GLS Axis-Mediated Glutamine Metabolic reprogramming in Cancer Cells
  1489. Light and Temperature Cues Elicit Metabolic reprogramming in the Non-phototrophic Bacterium Pseudomonas aeruginosa
  1490. HIF1α regulates early Metabolic changes due to activation of innate immunity in nuclear reprogramming
  1491. Action of the E2/ERβ/PTEN signaling in the Metabolic reprogramming of TCam 2, human melanoma cell line
  1492. Study on the Metabolic reprogramming of Lung Cancer Cells Regulated by Docetaxel Based on Metabolomics
  1493. Correction: Loss of the novel mitochondrial protein FAM210B promotes metastasis via PDK4-dependent Metabolic reprogramming
  1494. Role of Metabolic reprogramming toward fatty acid oxidation on tumor lymph node metastasis.
  1495. Mechanisms of the Metabolic shift during somatic cell reprogramming
  1496. Mitochondrial Dysfunction and Metabolic reprogramming in Chronic Kidney Disease
  1497. Metabolic reprogramming of Arginine in Tumor Stem Cells Facilitates Immune Escape
  1498. Macrophage polarization via Metabolic reprogramming
  1499. Metabolic reprogramming of the Cystic Fibrosis Neutrophil
  1500. Inflammation and Metabolic reprogramming of Lupus Monocytes-Mechanisms of the Pathobiology of Lupus Cardiovascular Disease
  1501. TARGETING Metabolic reprogramming OF RESPIRATORY SYNCYTIAL VIRUS INFECTION
  1502. Overcoming transarterial chemoembolization resistance through Metabolic reprogramming in hepatocellular carcinoma
  1503. Metabolic reprogramming IN ONCOGENE-DRIVEN HEPATOCELLULAR CARCINOMA: EFFECT OF LDHA KNOCK-DOWN
  1504. … -15. MET INHIBITION DRIVES PGC1A DEPENDENT Metabolic reprogramming AND ELICITS UNIQUE Metabolic VULNERABILITIES IN GLIOBLASTOMA
  1505. PDK4-mediated Metabolic reprogramming is involved in rituximab resistance in DLBCL via affecting the expression of MS4A1/CD20.
  1506. Metabolic reprogramming mediates macrophage polarization following myocardial infarction
  1507. CBMT-48. TARGETING Metabolic reprogramming WITH NANOCURCUMIN IN GLIOBLASTOMA MULTIFORME
  1508. Metabolic reprogramming in livers of mice with chronic liver disease
  1509. Macrophage Lineage Hdac3 Deletion Enhances Bone Healing and Promotes Lcn2-Dependent Macrophage Metabolic reprogramming
  1510. Peristalsis-like deformations influence tumor cell intravasation and Metabolic reprogramming in a novel colorectal cancer-on-chip model
  1511. MET Inhibition Elicits PGC1α-Dependent Metabolic reprogramming in Glioblastoma
  1512. Morphine Reduces Tumor Growth in Glioma Mouse Xenograft through Modulation of IDH1 Activity and Metabolic reprogramming
  1513. Metabolic reprogramming Drives P. Aeruginosa Airway Infection
  1514. Tumor microenvironment involvement in the Metabolic reprogramming induced by the PDK inhibitor dichloroacetate
  1515. Abstract PS17-28: Abrupt involution of lactating mammary gland induces Metabolic reprogramming conducive to pro-tumorigenic changes
  1516. Metabolic reprogramming supports microglial survival and immune function
  1517. Hypoxia-induced MIG-6 promotes glucose Metabolic reprogramming and tumorigenesis in triple-negative breast cancer
  1518. … ONC206 inhibits cell proliferation and induces apoptosis in uterine serous cancer through altering MAPK/AKT signaling network and Metabolic reprogramming
  1519. Glucose Metabolic reprogramming in HBV-related hepatocellular carcinoma through C-terminal truncated HBx protein suppression of TXNIP
  1520. The role of small conductance calcium-activated potassium channels in mitochondrial dysfunction: Targeting Metabolic reprogramming and calcium homeostasis
  1521. Metabolic reprogramming of the stromal epigenome in ovarian cancer metastasis
  1522. Resistance of triple-negative breast cancer cells to EGFR-targeted tyrosine kinase inhibitors is associated with Annexin A6-dependent Metabolic reprogramming
  1523. Investigating oncogenic FMS-like tyrosine kinase 3 (FLT3)-induced Metabolic reprogramming in acute myeloid leukaemia
  1524. Differential Metabolic reprogramming in Paenibacillus alvei-Primed Sorghum bicolor Seedlings in Response to Fusa…
  1525. Interleukin-22 drives a Metabolic adaptive reprogramming to maintain mitochondrial fitness and treat liver injury
  1526. OP0293 A FIRST-IN-CLASS Metabolic reprogramming AGENT, MBS2320, SELECTIVELY MODULATES IMMUNE CELL FUNCTION AND IMPROVES …
  1527. Metabolic reprogramming of the breast contributes to a cancer promoting milieu
  1528. Targeting Metabolic reprogramming and OXPHOS as a viable anti-melanoma strategy
  1529. Unravelingthe molecular mechanism behind Metabolic reprogramming caused by alterations of the enzyme PI3-kinase
  1530. Abstract LB-302: Mutant KRAS causes diverse Metabolic reprogramming and subsequent autophagy early in the pancreatic carcinogenesis
  1531. Lipid Metabolic reprogramming promotes hepatocarcinogenesis and targeted regulation of related drugs
  1532. Dynamic Metabolic reprogramming in innate immune cells: an early response to influenza infection that is essential for effector function
  1533. Pharmacological Inhibition of HIF-1 Alpha and Its Effects on Dendritic Cell Metabolic reprogramming
  1534. Deciphering Metabolic reprogramming in Diseases using Metabolome Analysis
  1535. Hedgehog signaling induced Metabolic reprogramming is essential for M2 polarization of macrophages in breast cancer
  1536. Circadian light-mediated endothelial Metabolic reprogramming
  1537. Metabolic reprogramming of the Retinal Pigment Epithelium in Retinitis Pigmentosa
  1538. Baff-br3 Signaling Promotes Aortic Aneurysm Formation via Metabolic reprogramming of B Cells
  1539. Abstract B107: Metabolic reprogramming enhances the efficacy of mTOR inhibition in colorectal cancer
  1540. 281-LB: PBI-4547 Orchestrates a Cross Talk between Liver and White Adipose Tissues to Correct Metabolic reprogramming
  1541. Modified ZIF-8 nanoparticles attenuate osteoarthritis by reprogramming the Metabolic pathway of synovial macrophages
  1542. Abstract B13: Utilizing Metabolic reprogramming to regulate fibroblast phenotype and reduce radiation fibrosis
  1543. Heterogeneity and Functional Divergence of Ly6C hi Monocytes in Acute Inflammation Identifies a Requirement for Metabolic reprogramming
  1544. Novel role for gelatinases in modulating Metabolic reprogramming associated with T cell receptor stimulation in CD4+ T cell
  1545. Metabolic reprogramming of Pseudomonas fluorescens in a Sulfur and Phosphate Limited Environment
  1546. AMPK/PGC-1α-mediated Metabolic reprogramming of hepatic stellate cells promotes stemness of hepatocellular carcinoma via metabolite lactate shuttle
  1547. Multiscale model predicts dynamics of Metabolic reprogramming in tumor spheroids
  1548. Metabolic reprogramming Determines Cardiomyocyte Proliferation in Both Neonatal and Adult Mice
  1549. Metabolic reprogramming of human monocytes/macrophages in obesity; implications in obesity-linked inflammation and cancers.
  1550. Role of heat shock factor 1 (HSF1) on activation-induced Metabolic reprogramming of T cells
  1551. CD28 regulates T cell Metabolic reprogramming through ARS2-dependent effects on alternative splicing
  1552. CARD9 Induces Metabolic reprogramming and Mediates the Immune Cascades in Dendritic Cell Against Pancreatic Cancer Progression
  1553. Metal-regulated transcription: zeocin affects copper/iron-regulated transcription and causes Metabolic reprogramming in saccharomyces cerevisiae
  1554. Dynamic Optimization Approach for Genome-Scale Investigation of Metabolic reprogramming Biological mathematics course projects
  1555. Metabolic reprogramming Induces Germinal Center B Cell Differentiation Through Epigenetic Control of Bcl6 Expression
  1556. Metabolic reprogramming in vemurafenib-resistant melanoma
  1557. Grain Size and Shape Reflects Variability in Metabolite Profile in Traditional Rice Varieties and Phyto-Protectant Mediated Metabolic reprogramming in Black Rice …
  1558. Metabolic reprogramming in Human and Mouse Corneal Endothelial Cells with Reduced Expression of SLC4A11
  1559. Regulation of Metabolic reprogramming by tumor suppressor genes in pancreatic cancer
  1560. Protective Role of Mitophagy Associated Metabolic reprogramming of Peripheral Macrophages During Tuberculosis
  1561. Fibroblast Generated Extracellular Vesicles Induces Metabolic reprogramming in Bone Marrow Derived Macrophages
  1562. Optimizing Active Immunotherapy of Melanoma through Metabolic reprogramming of Melanoma Antigen-Specific CD8+ T Cells Combined with Checkpoint Blockade
  1563. … -derived lactate inhibits methylation levels of SGK1 in myeloid-derived suppressor cells to promote GLUT1-mediated glucose uptake and Metabolic reprogramming
  1564. Metabolic reprogramming of the Retinal Pigment Epithelium Drives TGFβ2‐Induced Epithelial‐Mesenchymal Transition
  1565. The Genome‐wide Landscape of Oxidative Base Damage in Hypoxia; Potential Role in Metabolic reprogramming in Chronic Lung Disease
  1566. Dissecting the mechanisms of Notch/Akt-induced tumorigenesis: the role of energetic stress and Metabolic reprogramming
  1567. Epithelial-mesenchymal transition induced by cigarette smoke in lung epithelial cells is associated with Metabolic reprogramming and senescence
  1568. Role of heat shock factor 1 (HSF1) on Metabolic reprogramming of T-cells
  1569. … INHIBITION OF COMPLEMENT C5A/C5A RECEPTOR 1 DECREASES RENAL INJURY IN DIABETIC KIDNEY DISEASE VIA Metabolic reprogramming
  1570. Interleukin-33 regulates Metabolic reprogramming of the retinal pigment epithelium in response to immune stressors
  1571. … ONC206 inhibits cell proliferation and induces apoptosis in uterine serous cancer through altering MAPK/AKT/AMPK signaling network and Metabolic reprogramming
  1572. Hypoxia-Driven Long Noncoding RNA KMT2E-AS1 Modulates Histone Methylation to Control Endothelial Metabolic reprogramming and Pulmonary Hypertension
  1573. Separate and combined effects of Metabolic reprogramming interventions, autophagy inhibition, and carboplatin on murine triple-negative breast cancer cells
  1574. A FACS-Free Purification Method to Study Estrogen Signaling, Organoid Formation, and Metabolic reprogramming in Mammary Epithelial Cells
  1575. Arginase-2 is Essential for IL-10 Metabolic reprogramming of Inflammatory Macrophages at the Mitochondria
  1576. Mechanistic Target of Rapamycin, but Not the Integrated Stress Response, Promotes ATF4-Dependent Metabolic reprogramming in TGF-β-Treated Lung Fibroblasts
  1577. Metabolic reprogramming by GCN1 mediates metastatic reactivation and outgrowth at liver metastatic site in response to glutamine deprivation in pancreatic cancer
  1578. BRAF-mediated NAMPT overexpression induces a melanoma cell dedifferentiation program leading to Metabolic reprogramming and intrinsic resistant to BRAF …
  1579. HIF-1-dependent reprogramming of glucose Metabolic pathway of cancer cells and its therapeutic significance
  1580. … analysis of defense-related reprogramming in Sorghum bicolor in response to Colletotrichum sublineolum infection reveals a functional Metabolic web of …
  1581. 2-DG regain sensitivity of drug resistant colon cancer on 5-FU via blocking LKB1/Nrf2/Stat3 mediated Metabolic reprogramming
  1582. Metabolic and inflammatory reprogramming of macrophages by ONC201 translates in a pro‐inflammatory environment even in presence of glioblastoma cells
  1583. Metabolic remodeling during somatic cell reprogramming to induced pluripotent stem cells: involvement of hypoxia-inducible factor 1
  1584. Metabolomics based on UHPLC-QToF-and APGC-QToF-MS reveals Metabolic pathways reprogramming in response to tidal cycles in the sub-littoral species …
  1585. Human γδ T cell sensing of AMPK-dependent Metabolic tumor reprogramming through TCR recognition of EphA2
  1586. Cervical cancer metabolism: Major reprogramming of Metabolic pathways and cellular energy production
  1587. Viral reprogramming of Metabolism as an Approach to Identify Metabolic Vulnerabilities in Cancer
  1588. reprogramming of macrophages employing gene regulatory and Metabolic network models
  1589. Metabolic and epigenetic reprogramming in the arsenic-induced cancer stem cells
  1590. Metabolic reprogramming and altered isotope fractionation of cancerous cells of neural origin in the light of advanced atomic level mass spectrometry
  1591. … Pathway Supports MYC–miR-494–EZH2 Feed-Forward Circuit Necessary to Maintain Metabolic and Epigenetic reprogramming of Burkitt Lymphoma Cells
  1592. Obstacles in renal regenerative medicine: Metabolic and epigenetic parallels between cellular reprogramming and kidney cancer oncogenesis
  1593. Phenotypic and Metabolic Plasticity In Canine Cellular reprogramming
  1594. 3002–reprogramming OF SERINE METABOLISM IS A Metabolic VULNERABILITY IN FMS-LIKE TYROSINE KINASE 3 (FLT3) MUTANT ACUTE MYELOID …
  1595. In vivo Metabolic imaging reveals mitochondrial membrane potential reprogramming following Her2-targeted therapy and dormant disease
  1596. An ionic control of Metabolic-epigenetic reprogramming links inflammation to membrane potential-mediated nutrient acquisition
  1597. Metabolic Controls on Epigenetic reprogramming in Regulatory T Cells
  1598. Drought-Induced Gene Expression reprogramming Associated with Plant Metabolic Alterations and Adaptation
  1599. Differential responses on energy Metabolic pathway reprogramming between genotoxic and non-genotoxic hepatocarcinogens in rat liver cells
  1600. Metabolic Disorders and Transcriptional reprogramming in OA Pathogenesis
  1601. Fasting-mediated Metabolic and toxicity reprogramming impacts circulating microRNA levels in humans
  1602. The angiocrine Rspondin3 instructs interstitial macrophage transition via Metabolic–epigenetic reprogramming and resolves inflammatory injury
  1603. Applications of CRISPR in a microbial cell factory: From genome reconstruction to Metabolic network reprogramming
  1604. reprogramming microorganisms for the biosynthesis of astaxanthin via Metabolic engineering
  1605. Targeting clinical epigenetic reprogramming for chemoprevention of Metabolic and viral hepatocellular carcinoma
  1606. Caspase-10 inhibits ATP-citrate lyase-mediated Metabolic and epigenetic reprogramming to suppress tumorigenesis
  1607. Formaldehyde Causes Bone Marrow Failure Linked to Transcriptional reprogramming or Metabolic Deficiency
  1608. Root endophytic fungus Piriformospora indica improves drought stress adaptation in barley by Metabolic and proteomic reprogramming
  1609. Super-dosed butyrate induces a revisable Metabolic paralysis through transient mitochondrial reprogramming in the gut-brain axis
  1610. The Zscan4-Tet2 transcription nexus regulates Metabolic rewiring and enhances proteostasis to promote reprogramming
  1611. CRISPR/Cas9–mediated Metabolic pathway reprogramming in a novel humanized rat model ameliorates primary hyperoxaluria type 1
  1612. Metabolomics exploration of pseudorabies virus reprogramming Metabolic profiles of PK-15 cells to enhance viral replication
  1613. Neutral sphingomyelinase-2 (NSM 2) controls T cell Metabolic homeostasis and reprogramming during activation
  1614. Metabolic adjustments and gene expression reprogramming for symbiotic nitrogen fixation in legume nodules
  1615. Inhibition of Syk promotes chemical reprogramming of fibroblasts via Metabolic rewiring and H2S production
  1616. Systemic reprogramming of phytohormone profiles and Metabolic traits by virulent Diplodia infection in its pine (Pinus sylvestris L.) host
  1617. reprogramming Metabolic Networks and Manipulating Circadian Clocks for Biotechnological Applications
  1618. Role of notch and wnt signaling in Metabolic and epigenetic reprogramming of human dental pulp stem cells (DPSCs)
  1619. Targeting the Mild-Hypoxia Driving Force for Metabolic and Muscle Transcriptional reprogramming of Gilthead Sea Bream (Sparus aurata) Juveniles
  1620. Cardiac Characteristics of the Metabolic Syndrome: Transcriptomic Profile and Cardioprotective reprogramming in Response to Preconditioning and ACE-Inhibition
  1621. Epigenetic reprogramming Driven By Metabolic Alterations As A Mechanism Of EGFR–Tyrosine Kinase Inhibitor Resistance In Human Lung Adenocarcinoma
  1622. Bacillus velezensis 5113 induced Metabolic and molecular reprogramming during abiotic stress tolerance in wheat
  1623. The reprogramming of White Adipose Tissue to Brown Adipose Tissue Mediates Adverse Metabolic Dysfunction After a Burn Injury
  1624. Re: CRISPR/Cas9-Mediated Metabolic Pathway reprogramming in a Novel Humanized Rat Model Ameliorates Primary Hyperoxaluria Type 1
  1625. CD137 (4-1BB) stimulation leads to Metabolic and functional reprogramming of human monocytes/macrophages enhancing their tumoricidal activity
  1626. C-Terminal Binding Protein-1 Regulates Adventitial Fibroblast Metabolic and Mitochondrial reprogramming in Pulmonary Hypertension Through Sirtuins
  1627. Caspase-10 inhibits ATP-citrate lyase-mediated Metabolic and epigenetic reprogramming to suppress tumorigenesis
Related Posts

Red Wine

Rapamycin (Mtor Inhibition)

ANTI CARIOGENIC (Protecting From Tooth Decay)

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

Mandatory FDA Disclaimer: Not intended to diagnose, treat, cure or prevent any disease.

0
    0
    Your Cart
    Your cart is emptyReturn to Shop
    Continue Shopping